عضویت در سایت

Fahimeh Ramezani Tehrani


Curriculum Vita

 

 

 

Name: Fahimeh

Surname: Ramezani Tehrani

Nationality: Iranian

Date of birth: 05/05/1966

Place of Birth: Qazvin/Iran

Marital status: Married

 

 

Academic Educations:

 

  • Tehran University, School of Medicine                                        1984-1990

General Medicine

Tehran Iran

 

  • Tehran University School of Medicine                                         1990-1994

Obstetrics &Gynecology

Tehran Iran

 

  • Harvard School of Public Health                                                  2004-2005

Takemi Fellowship,

Boston, USA

 

 

Academic Position:

 

  • Assistant Professor of Medicine

Qazvin Univercity, School of Medicine

 

1994-2001

  • Associate Professor of Medicine                                                 

National Medical Research Center

 

2001- 2007

  • Associate Professor of Research Institute

for Endocrine Sciences

                                                                                 

2007-2011

  • Professor of Research Institute

for Endocrine Sciences                                                                                                                                               

 

2011-  to date

     

Official Positions:

 

  • Member, Council for Community Oriented Medical Education

1995-97

  • Member, Council for Reduction of Maternal Mortality

1995-97

  • Director of National Research Center for Reproductive Health

1997 - 2007

  • Director of National Reproductive Health Committee for Policy making

2000 - 2007

  • National Director of UNFPA Project

1997 - 2004

  • Member of Breast Cancer Commission

1999 – to date

  • Member of National AIDS Commission

2001 – to date

  • Member of National Committee of Elimination of Violence against women

2002 - 2006

  • Member of United Nation Country Team for Millennium Development Goals Campaign

2002 - 2007

  • Member of National Committee for Scientific Association

2006 - to date

  • Member of National Medical Ethic Committee

2007 - to date

  • Member of National Committee for Medical Researches

2007 - to date

  • Member of National Committee for Medical Journals

2009 – to date

 

 

Training Courses:

 

  • Workshop on Research Methodology –Iran 1997

 

  • Workshop on Advanced Methodology for Reproductive Health Research   Iran 1997

 

  • Workshop on Report Writing – Iran 1997

 

  • Workshop on Focus Group Discussion (by Judi Abbot) Iran 1998

 

  • Workshop on Qualitative Research (by Garsia Noonez) Iran 1998

 

  • Workshop on Operational Research, Nepal, C.S.T Committee WHO 1998

 

  • Workshop on Statistical Software (Stata) Iran 1998

 

  • Workshop on Statistical Software (SPSS) Iran 1998

 

  • Workshop on Statistical Software (Stata) Iran 1998

 

  • Workshop on Clinical Trial Iran 1998

 

  • Workshop on Focus Group Discussion (Advanced), Iran 1999

 

  • Workshop on Strengthening Researcher Capability, Iran 2000

 

  • Training course on Reproductive Health Research for Adolescence, Syria by WHOM, 2001

 

  • Workshop on Data Analyzing and Interpretation (by Khan) Iran, 2001

 

  • Workshop on Total Quality Management, Iran, 2002

 

  • Workshop on Strategic Planning, Iran, 2002

 

  • Training course on Counseling in HIV/AIDS Program Iran, 2003

 

  • Training course on Health Communication in Sensitive Issues, Iran 2003

 

  • Harm Reduction Workshop, Iran, 2004

 

  • Workshop on Integration of HIV/AIDS in PHC, Iran, 2004

 

  • Infertility training course, Boston IVF center, supervisor Dr. Selwyn P. Oskowitz, 2004-2005

 

Clinical training course:

 

 

  • Infertility training course, Boston IVF center, supervisor Dr. Selwyn P. Oskowitz, 2004-2005

 

  • Urogynecological surgery course, Urogynecologic Departement, supervisor Dr. Peter Rosenbelt , 2005-2006

 

  • Short training course on Laparoscopy & Hysterescopy, 2007,2008,2009,2010, each year one week.

 

 

Participation in International Conferences/ congresses/ seminars/ meetings

  1. 14th international AIDS conference, Spain, 7-12 July 2002, Oral presentation; Promotion of sexual reproductive health among youth of Islamshar.
  2. 25th congress medical women’s international association, Australia, 20-24 April 2002, Oral presentation; Unwanted Pregnancy in Tehran, What are the risk factors?
  3. 18th world conference on Health Promotion and Health Education, Australia, 26-30 April 2004, Oral presentation; Smoking habits of general practitioners in Iran.
  4. The 4th Congress of the European Society of Contraception & Reproductive Health Care, UK, 10-15 June 2004, Oral presentation; Peer group education in sexual reproductive health among university students.
  1. 3rd   Asia Pacific Conference on Reproductive and Sexual Health, Malaysia, 17-27 November 2005, Oral presentation; Knowledge, attitude and practice regarding HIV/AIDS among Iranian at risk population.
  2. Reproductive Disruptions (Childlessness, Adoption and other Reproductive Complexities), USA, 19-22 May 2005, Oral presentation; Gender disparity in reproductive health needs of youth.
  3. International Seminar on Sexual and Reproductive Transitions of Adolescents in Developing Countries, Mexico, 6-9 November 2006, Oral presentation; Reproductive Knowledge, Attitudes and Behavior Among Adolescent Males in Tehran, Iran, and risk taking sexual behaviors among adolescent boys aged 15-18 in Tehran.
  4. 15th International congress & ENDO EXPO SLS annual meeting, USA, 6-9 September 2006, Oral presentation; Laparoscopic treatment of polycystic ovaries with needle cautery.
  5. 13th world congress of gynecological endocrinology, Italy, 2007, Oral presentation; What are the risk factors of premature ovarian failure and early menopause among under coverage of Tehran East Health Center?
  6. 13th world congress of gynecological endocrinology, Italy, 2007, Poster presentation, Menarcheal age of mothers and daughters: Tehran Lipid and Glucose.
  7. 8th International Congress of  Endocrine Disorders & 2nd Arab-Iran congress of Endocrinology & Metabolism, Tehran, 27-28 October 2009, Oral presentation; Does considering polycystic ovary syndrome according to the Rotterdam consensus change its association with metabolic factors.
  8. 8th International Congress of  Endocrine Disorders & 2nd Arab-Iran congress of Endocrinology & Metabolism, Tehran, 27-28 October 2009, Oral presentation; Is ovarian ageing is delayed in women with PCOS?
  9. 1st Arab and Iranian Congress of Endocrinology and diabetes, Syria, 9-11 April 2008, Invited speaker; Prenatal complication of PCOS.
  10. 8th International Congress of  Endocrine Disorders & 2nd Arab-Iran congress of Endocrinology & Metabolism, Tehran, 27-28 October 2009, Chairman; Controversies in the definition of PCOS.
  11. UNFPA Report, UNFPA, 24 May2009, Invited speaker; Study on Reproductive Morbidities of women.
  12. 65th Annual meeting ASRM 2009, USA, 17-21 October, 2009, Poster presentation, Is polycystic ovary syndrome an exception for reproductive aging?
  13. 9th Asia and Oceania Thyroid Association Congress, Japan, November 2009, Poster presentation,Is thyroid function associated with components of the metabolic syndrome in euthyroid subjects of reproductive age?
  14. Human Reproduction,Vol.25,Supp.1-2010 (26th annual meeting ESHRE), Italy, 27-30 June 2010, Oral presentation; Whether age at menopause is predictable using AMH serum concentration?
  15. 20th SLS anniversary meeting and endo expo, California, 14-17 September, 2011, Oral presentation; Reproductive Outcome After Laparoscopic Treatment of Mild Endometriosis in Unexplained Infertility.
  16. 21st SLS annual meeting, Boston, 5-8 September, 2012, Oral presentation; Whether ovarian reserve is reduced in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.
  17. 10th congress on obstetrics and gynecology, 26-29 Sep 2013, Tehran. Iran. Oral presentation; rape.
  18. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. oral presentation; reproductive Endocrinology. Tehran: Razi Conference Hall.
  19. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. poster presentation; “Is there association between menopause and serum level of nitric oxide?” Tehran: Razi Conference Hall.
  20. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. poster presentation; “comparison of the effects of androgen on sexual function in women with and without polycystic ovary syndrome (PCOS)” Tehran: Razi Conference Hall.
  21. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. poster presentation; “Prevalence of pregnancy complications in differenr phenotypes of polycystic ovary syndrome” Tehran: Razi Conference Hall
  22. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. poster presentation; “Subclinical hypothyroidism in pregnancy and miscarriages” Tehran: Razi Conference Hall
  23. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. poster presentation; “Thyroid disorder symptoms and sign during pregnancy” Tehran: Razi Conference Hall.
  24. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation, Risk of metabolic syndrome in polycystic ovary syndrome: Tehran Lipid and Glucose Study. Tehran: Shahid Beheshti International Convention Center.
  25. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation, Gestational diabetes mellitus (GDM); current evidence and controversies. Tehran: Shahid Beheshti International Convention Center.
  26. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. Is Serum Androgen Level Predictive of Female Sexual Function in Women with Polycystic Ovary Syndrome? Tehran: Shahid Beheshti International Convention Center.
  27. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. Effects of Levothyroxine Treatment on Pregnancy Outcomes in Subclinical Hypothyroidism Pregnant Women. Tehran: Shahid Beheshti International Convention Center.
  28. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. The knowledge of Iranian general practitioners regarding diagnosis and treatment of polycystic ovary syndrome. Tehran: Shahid Beheshti International Convention Center.
  29. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. Risk of pre-hypertension and hypertension in polysystic ovary syndrom: Tehran Lipid and Glucose Study. Tehran: Shahid Beheshti International Convention Center.
  30. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. Correlations between Female Sexual Function Index and hormonal levels in women with polycystic ovary syndrome and healthy women. Tehran: Shahid Beheshti International Convention Center.
  31. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Refining the psychometric properties of health related quality of life among women with polycystic ovary syndrome (PCOSQ-50). Tehran: Shahid Beheshti International Convention Center.
  32. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Does unilateral oophorectomy increase the adverse cardio-metabolic effects attributed to surgical menopause? A community based cohort study. Tehran: Shahid Beheshti International Convention Center.
  33. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Does unilateral oophorectomy increase the adverse cardio-metabolic effects attributed to surgical menopause? A community based cohort study. Tehran: Shahid Beheshti International Convention Center.
  34. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Assessment the insulin resistance by Homa-IR in obesity and polycystic ovary syndrome: systematicreview and meta-analysis of observational studies. Tehran: Shahid Beheshti International Convention Center.
  35. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Evaluation the insulin sensitivity by Insulin Sensitivity Index (ISI) in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Tehran: Shahid Beheshti International Convention Center.
  36. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  Oral presentation. Cardiometabolic consequences of polycystic ovary syndrome; a population based cohort study with 15 years of follow up. Beijing, China.
  37. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  Oral presentation. Levothyroxine Treatment in pregnant women with autoimmune thyroid disease: prenatal and neonatal outcomes. Beijing, China.
  38.  
  39. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  poster presentation. Age-specific Anti-Müllerian Hormone and Ischemic Changes of Electrocardiography. Beijing, China.
  40. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  poster presentation. Whether billewicz scoring method precisely predicts thyroid dysfunction in pregnant women? A population based cohort study.. Beijing, China.
  41. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  poster presentation. Whether billewicz scoring method precisely predicts thyroid dysfunction in pregnant women? A population based cohort study.. Beijing, China.
  42. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  poster presentation. Menstrual cycle irregularity and metabolic disorders, a population based prospective study. Beijing, China.
  43. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  poster presentation. The Relationship between Serum Total Testosterone and Sexual Function among Post-menopausal Women. Beijing, China.
  44. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  poster presentation. Prenatal exposure to androgen excess affects sexual function of women with polycystic ovary syndrome in adulthood. Beijing, China.
  45. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  poster presentation. Association between idiopathic hirsutism and metabolic syndrome (Tehran Lipid and Glucose Study). Beijing, China.
  46. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  poster presentation. Co-Culture of Human Peripheral Blood Lymphocytes from Patients with Polycystic Ovary Syndrome (PCOS) with Ovarian Tumor Cell Lines (SKOV3, A2780): Study of Their In-Vitro Immunological Interactions and Comparison to Healthy Women. Beijing, China.
  47. 17th International Congress of Endocrinology, ICE-CSE Aug 31 – Sept 4th 2016.  poster presentation. The study of TNF-α cytokine production ,expression of CD8 marker and proliferation of peripheral blood lymphocyte of multiparous women compared with nulliparous women by Co-culture with MDA-231 and MCF-7 breast tumor cell lines. Beijing, China.
  48. 14th Annual AE-PCOS Meeting, 10-12 Nov 2016. Oral Presentation. Australia.

 

 

Publications:

  1. Barooti E, Ramezani Tehrani F, Hydari M, Mohammad K. Prevalence of primary infertility based on marriage age, Hakim Journal 1999; 2(2): 88-93.
  2. Jahanfar S, Ramazai Tehrani F, Sadat Hashemi M. Unwanted Pregnancy and Abortion. Iranian Journal of Nursing and Midwifery summer 2000; 13(25): 23-27.
  3. Ramezani Tehrani F, Hejazi S, Aflaki S. effective factors on correct contraceptive use. The Journal of Qazvin University of Medical Science Summer 2000; 4(14): 37-43.
  4. Jahanfar Sh, Sadat Hashemi SM, Ramezani Tehrani F. The assessment of in fluency factors on unwanted pregnancy using logic regration analysis; a study among women refer to clinic Tehran medical university. Daneshvar  2000, 8(29): 21-26.
  5. Ramezani Tehrani F, Kazem M, Rahgozar M, Naghavi M. Knowledge and practice of Iranian women toward cervical cancer. Medical Journal of Reproduction & Infertility 2001; 2(5): 50-56
  6. Rahgozar M, Kazem M,  Ramezani Tehrani F. Trend of still birth rate in Iranian women aged 15-49 years during four decade from 1957-1996, Hakim Research Journal Summer 2001; 4(2): 85-91.
  7. Ramezani Tehrani  F, Khaladj Abadi Farahani F, Sadat Hashemi M. Factors influencing contraceptive use in Tehran. Family Practice 2001; 18(2): 204-208.
  8. Ramezani Tehrani F, Sadat Hashemi SM, Heidari Seraj M. Comparison of tubal ligation by bipolar electroagulation and filshie-clips. The journal of Qazvin University of Medical Science Winter 2002; 20: 35-41.
  9. Seyf Rabiei MA, Ramezani Tehrani F, Hatmi Z. Wife Abuse and Related Factors. Women in Development & Politics 2002; 4(1): 25-52
  10. Ramezani Tehrani F, Pakniyat H, Naji A, Asefzadeh S. Thyroid hormone Variations in pre-eclampsia. The Journal of Qazvin University of Medical Science 2002; 24: 18-23.
  11. Jahanfar S, Ramezani Tehtani F, Hashemi M. Early complication of menopause among women in Tehran. Reproduction & Infertility 2002; 3(10): 31-40.
  12. Jahanfar Sh, Ramezani Tehrani F, Hashemi M. The prevalence of unwanted pregnancies and its effective factors  in 10 cities, The Journal of Faculty of Medicine. Tehran University of Medical Science 2002; 60(4): 334-340.
  13. Ramezani Tehrani F, Aghaee M, Asefzadeh S. The comparison of thyroid function tests in cord blood following cesarean section or vaginal delivery. International  Journal of Endocrinology and Metabolism 2003; 1(1): 22-26.
  14. Simbar M, Ramezani Tehrani F, Hashemi Z. The needs of reproductive health of the university students of Qazvin. The Journal of Qazvin Univ. of Med.Sci Autumn Supplement 2003; 28: 5- 13.
  15. Mohammadi MR, Mohammad K, Khalajabadi Farahani F, Alikhani S, Zare M, Ramezani Tehrani F, A. et al. Reproductive knowledge, attitude and practice of Tehranian adolescent boys ahed 18 years, 2002. Reproduction & Infertility Summer 2003; 4(3): 237-250.
  16. Simbar M, Ramezani Tehrani F, Hashemi Z. Knowledge, attitude and practice of reproductive health of university students. Pajohande 2003; 8(4): 9-15.
  17. Simbar M, Ramezani Tehrani F, Hashemi Z. Sexual-Reproductive Health Belief Model of college students. South Teb Aug 2004; 7(1): 70-78.
  18. Simbar M, Ramezani Tehrani F, Hashemi Z. Reproductive health knowledge, attitudes and practices of Iranian college students. Eastern Mediterranean Health Journal 2005;  11(5-6): 888-897.
  19. Mohammadi MR, Mohammad K, Khalaj Abadi Farahani F, Alikhani S, Zare M, Ramezani Tehrani F, et al. Reproductive Knowledge, Attitudes and Behavior Among Adolescent Males in Tehran, Iran. International Family Planning Perspectives 2006; 32(4): 35-44.
  20. Ramezani Tehrani F, Malekafzali H, Jalalinia Sh, Rostami dovvom M, Peikari N. General practitioners knowledge about smoking cessation approaches. Medical Science Journal of Islamic Azad University 2006; 16(3): 155-159.
  21. Simbar M, Ramezani Tehrani F, Hashemi Z, Zham H, Fraser IS. A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature. J Fam Plann Reprod Health Care 2007; 33(4): 271-276.
  22. Ramezani Tehrani F, Malekafzali H, Djalalinia Sh, Rostami Dovom M, Peikari N. Training of general practitioners about smoking cessation counseling. Hakim Summer 2007; 10(2): 15-20.
  23. Mohammad K, Khalaj Abadi Farahani F, Mohammadi MR, Alikhani S, Zare M, Ramezani Tehrani F, et al. Sexual Risk-Taking Behaviors among Boys Aged 15–18 Years in Tehran, 20. Journal of Adolescent Health  2007 oct; 41(4): 407-414.
  24. Ramezani Tehrani F, Malekafzali H. Knowledge, attitudes and practices concerning HIV/AIDS among Iranian at-risk sub-populations. Eastern Mediterranean Health journal 2008; 14(1): 142-156.
  25. Paikari N, Ramezani Tehrani F, Malek-Afzali H, Jalalinia Sh. Assessment of key stockholders regarding the practice of counseling centers for university students. Journal of medical council of Islamic republic of Iran 2008, 25(4): 431-439.
  26. Ramezani Tehrani F, Moini A, Khalaj F, Skandarloo M. Laparoscopic treatment of polycystic ovaries with needle cautery in Clomiphen resistant patients. Journal of Zanjan University of medical sciences 2008; 16(62): 59-67.
  27. Ramezani Tehrani F, Solaymani-Dodaran M, Aziz F. A single test of antimu¨llerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause: The Journal of The North American Menopause Society 2009; 16(4): 797-802.
  28. Farahmand M, Ramezani Tehrani F, Azizi F. The Influence of Serum Lipoprotiens and Body Mass Index on the Age of Menarche. Iranian Journal of Endocrinology and Metabolism 2009; 11(4): 415-421.
  29. Simbar M, Nahidi F, Ramezani Tehrani F, Ramezankhani A. Father’s educational needs for perinatal care in urban Iran: A qualitative approach, J. Biosoc. Sci 2010, Vol. 42, pp. 633-641.
  30. Ramezani Tehrani F, Mirmiran P, Zahedi-Asl S, Nakhoda K, Azizi F. Menarchel age of mothers and daughters: Tehran Lipid and Glucose study. Eastern Mediterranean Health Journal 2010; 16(4): 391-395.
  31. Ramezani Tehrani F, Solaymani-Dodaran M, Hedayati M, Azizi F. Is polycystic ovary syndrome an exception for reproductive aging? Human Reproduction 2010; 25(7): 1775-1781.
  32. Peykari N, Ramezani Tehrani F, Malekafzali H, Rostami Dovvom M, Djalalinia Sh. Smoking Habits among Iranian General Practitioners. J Egypt Public Health Assoc 2010; 85(1): 96-112.
  33. Ramezani Tehrani F, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum Anti -Mullerian Hormone serum concentration. Menopause: The Journal of The North American Menopause Society 2011; 18(7): 766-770.
  34. Peykari N, Ramezani Tehrani F, Malek-afzali H, Hashemi Z, Djalalinia Sh. An experience of Peer Education Model among Medical Science University Students in Iran. Iranian J Publ Health 2011; 40(1):  57-62.
  35. Ramezani Tehrani F, Simbar M, Abedini M. Reproductive morbidity among Iranian women; issues often inappropriately addressed in health seeking behaviors. BMC Public Health 2011 Nov 14; 11: 863.
  36. Peykari N, Ramezani Tehrani F, Baradaran Eftekhari M, Malekafzali H, Dejman M. Rosemary Neot, Shirin Djalalinia, A peer-based study on adolescence nutritional health: A lesson learned from Iran. J Pak Med Assoc 2011; 61(6): 549-554.
  37. Ramezani Tehrani F, Hashemi S, Simbar M, Shiva N. Screening of the pelvic organ prolapse without a physical examination; (a community based study). BMC Women’s Health 2011 nov; 15; 11: 48.
  38. Simbar M, Nahidi F, Ramezani-Tehrani F, Akbarzadeh A. Educational needs assessment for men’s participation in perinatal care. Eastern Mediterranean Health Journal 2011; 17( 9): 689-696.
  39. Ramezani Tehrani F. LETTERS TO THE EDITOR. Menopause: The Journal of The North American Menopause Society 2011; 18(12): 1334-1335.
  40. Peykari N, Ramezani Tehrani F, Malek Afzali H, Baradaran Eftekhari M, Djalalinia Sh. The key stakeholders' opinions regarding university counseling centers: An experience from Iran. J Res Med Sci 2011; 16(9): 1202-9.
  41. Ramezani Tehrani F, Rashidi H,  Azizi F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reproductive Biology and Endocrinology 2011 Nov 1;  9: 144..
  42. Ramezani Tehrani F, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum antimu¨llerian hormone concentration. Menopause: The Journal of The North American Menopause Society 2011; 18(7): 766-770.
  43. Ramezani Tehrani F, Simbar M, Tohidi M,  Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reproductive Biology and Endocrinology 2011 Mar 25;  9: 39.
  44. Hosseinpanah F, Barzin M, Ramezani Tehrani F, Azizi F. The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS Prevalence Study. Clinical Endocrinology 2011; 75(5): 962-697.
  45. Ramezani Tehrani F, Tohidi M, Rostami Dovom M, Azizi F. A Population Based Study on the Association of Thyroid Status with Components of the Metabolic Syndrome. Diabetes & Metabolism 2011; 2(8): 1-5.
  46. Ramezani Tehrani F, Hashemi S, Hasheminia M, Azizi F. Metabolic Disorders in Women with Previous Gestational Diabetes Mellitus, Tehran Lipid and Glucose Study. Iranian Journal of Endocrinology and Metabolism Novamber 2011; 13(4):  339-345.
  47. Ramezani Tehrani F, Simbar M, Abedini M. Prevalence of Reproductive Morbidity in Four Selected Provinces in Iran. Hakim Research Journal 2011; 14(1): 32- 40.
  48. Farahmand M, Ramezani Tehrani F, Azizi F. Menopause age and affecting factors in Tehran Lipid and Glucose Study (TLGS). The Journal of Qazvin University of Medical Sciences 2011; 15(1): 55.
  49. Ramezani Tehrani F, Amiri P, Simbar M, Rostami Dovom M, Azizi F. Do Men Consider Health as a Priority? A Qualitative Study. Hakim Research Journal  2011; 13(4): 241-249.
  50. Ramezani Tehrani, FTohidi, MRostami, MAsgari, SAzizi, F. The association between sub-clinical hypothyroidism and metabolic syndrome: A population based study. Iranian Journal of Endocrinology and Metabolism.Volume 13, Issue 1, 2011, Page 123
  51. Jalalinia Sh, Ramezani Tehrani F, Baradaran Eftekhari M, Peykari N. Qualitative study of adolescences opinion among nutritional habits and believes. Medical Sciences Journal of Islamic Azad University Winter 2011; 20(4): 258-264.
  52. Ramezani Tehrani F, Farahmand M, Amiri P, Paikari N, Azizi F. Women’s Perception Regarding to Healthy Nutrition Inhibitors: a Qualitative Research in Tehran Lipid and Glucose Study (TLGS). Iranian Journal of Endocrinology and Metabolism May 2011; 13(1): 48-57.
  53.  Zadeh-Vakili A, Ramezani Tehrani F, Hosseinpanah F. Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetology & Metabolic Syndrome 2011, 3(18): 1-6.
  54. Djalalinia Sh, Ramezani Tehrani F, Malekafzali H, Rostami Dovvom M. Training of general practitioners about smoking cessation counseling. J Pak Med Assoc 2011; 61(5): 449-452.
  55. Ramezani Tehrani F, Hashemi S, Hasheminia M, Azizi F. Follow-up of women with gestational diabetes in the Tehran Lipid and Glucose Study (TLGS): A population-based cohort study. J. Obstet. Gynaecol. Res 2012; 38(4), 698–704.
  56. Djalalinia Sh, Ramezani Tehrani F, Malek Afzali H, Peykari N, Baradaran Eftekhari M. Community Mobilization for Youth Health Promotion: A Lesson Learned From Iran. Iranian J Publ Health 2012; 41(4): 55-62.
  57. Lotfi R, Ramezani Tehrani F, Yaghmaei F, Hajizadeh E. Barriers to condom use among women at risk of HIV/AIDS: a qualitative study from Iran. BMC Women's Health 2012 may, 24; 12: 13.
  58. Zadeh-Vakili A, Ramezani Tehrani F, Hashemi S, Amouzegar A, Azizi F. Relationship between Sex Hormone Binding Globulin, Thyroid Stimulating Hormone, Prolactin and Serum Androgens with Metabolic Syndrome Parameters in Iranian Women of Reproductive Age. Diabetes & Metabolism 2012; S2-008: 1-8.
  59. Farahmand M, Ramezani Tehrani F, Azizi F. Whether age of menarche is influenced by body mass index and lipoproteins profile? A retrospective study. Iran J Reprod Med July 2012; 10(4):  373-378.
  60. Hashemi S, Simbar M, Ramezani-Tehrani F,  Shams J, Alavi Majd H. Anxiety and success of in vitro fertilization. European Journal of Obstetrics & Gynecology and Reproductive Biology Sep 2012; 164(1): 64.
  61. Ramezani Tehrani F. A long way is ahead of prediction of menopause! Int J Endocrinol Meta 2012, 10(3): 521-522.
  62. Ramezani Tehrani F, Farahmand M, Abedini M, Hashemi Z. Prevalence of vaginitis in Iranian women-- symptoms and clinical association. Medical Science Journal of Islamic Azad University  2012; 22(1): 68.
  63. Lotfi R, Ramezani Tehrani F, Yaghmaei F, Hajizadeh E. Socioenvironmental barriers of using condom among women at risk of HIV/AIDS. payesh September- October 2012; 11(5):  669-678.
  64. Ramezani Tehrani F, Farahmand M, Amiri P, Ghanbarian A, Azizi F. Healthy nutrition inhibitors from the perception of Tehranian men: A qualitative study. payesh September- October 2012; 11(5): 725-735.
  65. Haghighi S, Yaghmaei P, Hashemi F, Saadati N, Ramezani Tehrani F, Hedayati M. The association between serum chemerin concentration and polycystic ovarian syndrome. Tehran University Medical Journal August 2012; 70(5), 320-324.
  66. Farahmand M, Ramezani Tehrani F, Mehrabi Y, Azizi F. Occurrence of Metabolic Syndrome and Components in Postmenopausal Women with Natural or Surgical Menopause. Iranian Journal of Endocrinology and Metabolism July 2012; 14(2): 117-126.
  67. Hashemi F, Yaghmaei P, Saadati N, Haghighi Poodeh S, Ramezani Tehrani F, Hedayati M. Association of serum adipsin levels with polycystic ovarian Syndrome. Razi Journal of Medical Sciences Aug-Sep 2012; 19(99): 1-6.
  68. Hashemi S, Ramezani Tehrani F, Hasheminia M, Azizi F, Evaluation the Risk of Metabolic Disorder in Women with Previous Preeclampsia Participated in Tehran Lipid and Glucose Study. Iranian Journal of Endocrinology and Metabolism March 2012; 13(6): 643-650.
  69. Simbar M, Nahidi F, Ramezani Tehrani F, Ramezankhani A, Akbar Zadeh AR. Educational needs assessment for fathers' participation in perinatal care. Payesh, January - February 2012;  11(1): 39-49.
  70. Saadati N, Yaghmaei P, Haghighi S, Hashemi F, Ramezani Tehrani F, Hedayati M. Association of Serum Omentin Levels in Women with PolyCystic Ovarian Syndrome. Iranian Journal of Endocrinology and Metabolism, November 2012; 14(4): 375-379.
  71. Ramezani Tehra F, Hashemi S, Robab Allameh M. Prevalence of premenstrual syndrome and some of its relative factors in reproductive age. Ofogh-e-Danesh Journal, 2012; 18 (3): 121-127.
  72. Emadi M, Ramezani Tehrani F, Yaghmaei P, Sheikholeslami S, Hedayati M. Serum adiponectin levels and its association with insulin resistance and obesity in women with poly cystic ovarian syndrome. RJMS, 2012; 19 (101): 1-7.
  73. Ramezani Tehrani F, Farahmand M, Mehrabi Y, Malek Afzali H, Abedini M. Prevalence of female sexual dysfunction and its correlated factors: a population based study(Views: 5). Payesh, November -December 2012; 11(6): 869-875.
  74. Lotfi R, Ramezani Tehrani F, Merghati Khoei E, Yaghmaei F, Dworkin Sh L. How Do Women at Risk of HIV/AIDS in Iran Perceive Gender Norms and Gendered Power Relations in the Context of Safe Sex Negotiations? Arch Sex Behav, 2013 jul; 42(5): 873-881.
  75. Farahmanf F, Ramezani Tehrani F, Amiri P, Azizi F. Barries to healthy nutrition: perceptions and experiences of Iranian women. BMC Public Health, 2012 Dec 10;12: 1064.
  76. Farahmand M, Ramezani Tehrani F, Pourrajabi L, Najafi M, Azizi F. Factors associated with menopausal age in Iranian women: Tehran Lipid and Glucose Study. The journal of obstetrics and gynaecology research, 2013 Apr; 39(4): 836-841.
  77. Djalalinia SH, Ramezani Tehrani F, Malek Afzali H, Hejazi F, Peykari N. Parents or School Health Trainers, which of them is Appropriate for Menstrual Health Education? Int J Prev Med, Sep 2012; 3(9): 622-627.
  78. Ramezani Tehrani, FZadeh Vakili, AHashemi, SAmuzegar, AAzizi, F. Associations between hormonal profiles of urban Iranian women of reproductive age: A community based study of four provinces  Iranian Journal of Endocrinology and MetabolismVolume 14, Issue 1, 2012, 32-38.
  79. Zadeh-Vakili A, Ramezani Tehrani F, Daneshpour M, Zarkesh M, Saadat N, Azizi F. Genetic polymorphism of vitamin D receptor gene affects the phenotype of PCOS. Gene, 2013 Feb 15; 515(1): 193-196.
  80. Hashemi S, Seddigh S, Ramezani Tehrani F, Hasanzadeh Khansari SM, Khodakarami N. Sexual ehavior of Married Iranian Women, Attending Taleghani Public Health Center. J Reprod Infertil. 2013;14(1): 34-38.
  81. Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone. J Clin Endocrinol Metab. 2013 Feb; 98(2): 729-735.
  82.  Nasiri Amiri F., Ramezani Tehrani F., Simbar M., Mohammadpour Tahmtan R. Concerns Of Women With Polycystic Ovary Syndrome: A Qualitative Study Iranian Journal Of Endocrinology And Metabolism (Ijem)   May 2013 , Volume 15 , Number 1 (Sn 67);  41 To 51.
  83. Ramezani FR, Moslehi N,  Asghari G, Gholami R, Mirmiran P, Azizi F. Intake of Dairy Products, Calcium, Magnesium, and Phosphorus in Childhood and Age at Menarche in theTehran Lipid and Glucose Study. PLOS. 2013 Feb; 8(2): e57696.
  84. Hashemi S, Tehrani FR, Mehrabi Y, Azizi F. Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran Lipid and Glucose Study). J. Obstet. Gynaecol. Res. J Obstet Gynaecol Res. 2013 may; 39(5): 891-897.
  85. Hashemi S, Seddigh S, Ramezani Tehrani F, Hasanzadeh Khansari SM, Khodakarami N. Sexual behavior of Married Iranian Women, Attending Taleghani Public Health Center. J Reprod Infertil. 2013 Jan;14(1): 34-38.
  86. Rahmani M, Earp MA, Ramezani Tehrani F, Ataee M, Wu J, n Treml M, Nudischer R, P-Behnami S, Consortium R, Perry J R-B, Murabito JM, Azizi F. Angela Brooks-Wilson. Shared genetic factors for age at natural menopause in Iranian and European women. Human Reproduction. 2013 jul; 28(7). 1987-1994.
  87. Ramezani Tehrani F, Momenan AA, Bahri khomami M, Azizi F. Does lactation protect mothers against metabolic syndrome. Iranian Journal of Diabetes and Lipid Disorders. 2013; 12(1): 47-55.
  88. Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Mohammadpour Tahmtan AR. Concerns of Women with Polycystic Ovary Syndrome: A Qualitative Study. Iranian Journal of Endocrinology and Metabolism. 2013; 15 (1): 41-51. 
  89. Mehran P, Simbar M, Shams J, Ramezani-Tehrani F, Nasiri N. History of perinatal loss and maternal–fetal attachment behaviors. Women Birth. 2013 Sep;26(3):185-9.
  90. Sadat Hosseini M, Ramezani Tehrani F, Azizi F. The lack of association between idiopathic hirsutism and metabolic disturbances: Iranian PCOS Prevalence Study. Gynecol Endocrinol. 2013 Sep; 29(9): 821-825.
  91. Hosseinpanah F, Barzin M, Erfani H, Serahati S, Ramezani Tehrani F, Azizi F. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Clin Endocrinol (Oxf). 2014 Jul;81(1):52-7.
  92. Lotfi R, Fahimeh Ramezani Tehrani, Farideh Yaghmaei. Social support and HIV prevention among women “at risk”: a qualitative study. Payesh. October-November 2013; 12(5): 537-544 .
  93. Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Mohammadpour Tahamtan RA. Components of quality of life of women with polycystic ovary syndrome: a qualitative study. Payesh.   Payesh 2013; 12: 657-669.
  94. Tabatabaei M, Zarnani AH, Nikoo Sh, Keshavarzi B, Ramzani Tehrani F, Arefi S,  Mirzadegan E, Mosaffa N. Isolation and Immunophenotypjng of human amniotic epithelial cells. Journal of the faculty of medicine; 2013, 37(1), 1-7.
  95. Khajehpour M, Simbar M, Jannesari S, Ramezani-Tehrani F, Majd HA. Health status of women with intended and unintended pregnancies. Public Health. 2013 Jan;127(1):58-64.
  96. Ramezani Tehrani F, Noroozzadeh M, Zahediasl S, Ghasemi A, Piryaei A, Azizi F. Prenatal testosterone exposure worsen the reproductive performance of male rat at adulthood. PLoS One. 2013 Aug 15;8(8):e71705.
  97. Ramezani Tehrani F, Daneshpour M, Hashem S, Zarkesh M,  Azizi F. Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS. Iran J Reprod Med. March 2013; 11(3):  185-194.
  98. Ramezani Tehrani F, Minooee S, Simbar M, Azizi F. A Simpler Diagnostic Method to Assess Hirsutism in the Iranian Population: Based on Modified Ferriman- Gallwey Scoring System (a Community Based Study). Iranian Journal of Endocrinology and Metabolism. September 2013; 15(3): 303-310.
  99. Maryam F, Ramezani Tehrani F, Momenan AA, Ghanbarian A, Azizi F. Comparison of metabolic changes after natural menopause and surgical menopause. Payesh, November-December 2013; 12(6): 411-416.
  100. Farahmand M, Ramezani Tehrani F, Momenan AA, Ghanbarian A, Azizi F. Comparison of metabolic changes after natural menopause and surgical menopause. Payesh. November-December 2013; 12(6): 411-416.
  101. Hashemi S, Ramezani Tehrani F, Simbar M, Abedini M, Bahreinian H, Gholami R. Evaluation of sexual attitude and sexual function in menopausal age; a population based cross-sectional study. Iran J Reprod Med. August 2013;11(8):631-636.
  102. Djalalinia S, Ramezani-Tehrani F, Malekafzali H, Hejazi F, Peykari N. Development and evaluation of a nutritional health program for adolescents. Iran J Nurs Midwifery Res. 2013 Sep;18(5):425-427.
  103. Nasiri Amiri F, Ramezani Tehran F, Simbar M, Mohammadpour Tahamtan RA. Components of quality of life of women with polycystic ovary syndrome: a qualitative study. November-December 2013; 12(6): 413-416.
  104. Ramezani Tehrani F, Behboudi-Gandevani S, Ghanbarian A, Azizi F. Effect of menopause on cardiovascular disease and its risk factors: a 9-year follow-up, population-based, cohort study. Climacteric. 2014 Apr; 17(2): 164-172.
  105. Tabatabaei M, Mosaffa N, Nikoo S, Bozorgmehr M, Ghods R, Kazemnejad S, Rezania S, Keshavarzi B, Arefi S, Ramezani-Tehrani F, Mirzadegan E, Zarnani AH. Isolation and partial characterization of human amniotic epithelial cells: the effect of trypsin. Avicenna J Med Biotechnol. 2014 Jan;6(1):10-20.
  106. Hashemi S, Ramezani Tehrani F, Noroozzadeh M, Azizi F. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age. Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172: 51-5.
  107. Hosseinpanah F, Barzin M, Keihani S, Tehrani FR, Azizi F. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study. Clin Endocrinol (Oxf). 2014 Jul;81(1):93-9.
  108. Ramezani Tehrani F, Minooee S, Azizi F. Validation of a simplified method to assess hirsutism in the Iranian population. Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:91-5.
  109. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:100-5.
  110. Rostami Dovvom M, Ramezani Tehrani F, Abedini M, Amirshekari G, Mehrabi Y. Prevalence of Primary and Secondary Infertility among 18-49 Years Old Iranian Women: a Population-based Study in Four Selected Province. Hakim Medical Journal, 2014(Issue 4). 294-301.
  111. Ramezani Tehrani F, Noroozzadeh M, Zahediasl S, Piryaei A, Azizi F. Introducing a rat model of prenatally androgen-induced polycystic ovary syndrome in adulthood. Exp Physiol. 2014 May1; 99(5): 792-801.
  112. Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Mohammadpour Thamtan RA, Shiva N. Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran. Iran Red Crescent Med J. 2014 Feb;16(2):e12423.
  113. Farshchian F, Kazeruni F, Ramezani Tehrani F, Parsian H, Namaki S, Amirrasouli H, Moslemi A, Rahimipour A.  Evaluation of the relationship between serums Visfatin and Resistin levels with BMI in PCOS young women. Journal of Paramedical Sciences (JPS). Spring 2014 5(2): 79-84.
  114. Hajizadeh S, Vahid Dastjerdi M, Moradi-Lakeh M, Khajavi A, Farzadfar F, Zandian E, Raza O, Tehrani FR, Farzadfar F. The trend of national and subnational burden of maternal conditions in iran from 1990 to 2013: the study protocol. Arch Iran Med. 2014 Mar;17(3):198-203.
  115. Ramezani Tehrani F, Momenan AA, Khomami MB, Azizi F. Does lactation protect mothers against metabolic syndrome? Findings from the Tehran Lipid and Glucose Study. J Obstet Gynaecol Res. 2014 Mar;40(3):736-42.
  116. Ramezani Tehrani F, Dólleman M, van Disseldorp J, Broer SL, Azizi F, Solaymani-Dodaran M, Fauser BC, Laven JS, Eijkemans MJ, Broekmans F. Predicting menopausal age with anti-Müllerian hormone: a cross-validation study of two existing models. Climacteric. 2014 Oct; 17(5): 583-590.
  117. Ramezani Tehrani F, Minooee S, Azizi F. The comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non hirsute women; a population based study. Eur J Endocrinol. 2014 Aug;171(2):199-207.
  118. Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Montazeri A, Mohammadpour Thamtan RA. The experience of women affected by polycystic ovary syndrome: a qualitative study from iran. Int J Endocrinol Metab. 2014 Apr 1;12(2):e13612.
  119. Sevil Hakimi, Masoumeh Simbar, Fahimeh Ramezani Tehrani. Concerns of menopausal women: a phenomenological study in North West Iran. payesh. 2014; 13(3): 321-330.
  120. Hashemi S, Ramezani Tehrani F, Farahmand M, Bahri Khomami M. Association of PCOS and Its Clinical Signs with Sexual Function among Iranian Women Affected by PCOS. J Sex Med. 2014 Oct; 11(10): 2508-14.
  121. Ramezani Tehrani F, Bahri M, Gholami R, Hashemi S, Nakhoda K, Azizi F. Secular trend of menopausal age and related factors among Tehrani women born from 1930 to 1960; Tehran Lipid and Glucose Study. Arch Iran Med. 2014 Jun;17(6):406-10.
  122. Ramezani Tehrani F, Noroozzadeh M, Zahediasl S, Piryaei A, Hashemi S, Azizi F. The time of prenatal androgen exposure affects development of polycystic ovary syndrome-like phenotype in adulthood in female rats. Int J Endocrinol Metab. 2014 Apr 1;12(2):e16502.
  123. Farahmand M, Ramezani Tehrani F, Simbar M, Mehrabi Y, Khalili D, Azizi F. Does metabolic syndrome or its components differ in naturally and surgically menopausal women? Climacteric. 2014 Aug;17(4):348-55.
  124. Hakimi S, Simbar M, Ramezani Tehrani F. Perceived concerns of azeri menopausal women in iran. Iran Red Crescent Med J. 2014 May;16(5):e11771.
  125. Tehrani, F.RMirmiran, PGholami, RMoslehi, NAzizi, F Factors influencing menarcheal age: Results from the cohort of Tehran Lipid and glucose study . International Journal of Endocrinology and Metabolism. 2014 July; 12(3): e16130.
  126. Djalalinia, SRamezani Tehrani, FMalekafzali, HPeykari, N. Peer education: Participatory qualitative educational needs assessment. Iranian Journal of Public Health. Volume 42, Issue 12, 2013, Pages 1422-1429.
  127. Ramezani Tehrani, F.a Mirmiran, P.b Gholami, R.a Moslehi, N.b Ghanbarian, A.d Azizi, F. Correlation between menarcheal age and certain demographic characteristics. Iranian Journal of Endocrinology and Metabolism. Volume 15, Issue 1, 2013, Pages 52-58.
  128. Ramezani Tehrani F, Farahmand M, Simbar M, Malek Afzali H. Factors Associated with Sexual Dysfunction; A Population Based Study in Iranian Reproductive Age Women. Arch Iran Med. 2014 Oct;17(10):679-684.
  129. Tehrani FR1, Erfani H2, Cheraghi L3, Tohidi M4, Azizi F5. Lipid profiles and ovarian reserve status: a longitudinal study. Hum Reprod. 2014 Nov;29(11):2522-9.
  130. Farshchian F, Ramezani Tehrani F, Amirrasouli H, Rahimi Pour H, Hedayati M, Kazerouni F, Soltani A. Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome. Int J Endocrinol Metab. 2014 Jul 1;12(3):e15503.
  131. Tehrani FR, Rashidi H, Khomami MB, Tohidi M, Azizi F. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reprod Biol Endocrinol. 2014 Sep 16;12:89.
  132. Rostami Dovom M, Ramezani Tehrani F, Abedini M, Amirshekari G, Hashemi S, Noroozzadeh M. A population-based study on infertility and its influencing factors in four selected provinces in Iran (2008-2010). Iran J Reprod Med. August 2014, 12( 8); 561-566.

 Hashemi S, Ramezani Tehrani F, Noroozzadeh M, Rostami Dovom M, Azizi F Infertility, the Most Adverse Outcome Among SexualFunction Outcome Affecting of Iranian Women with Polycystic Ovarian Syndrome. Iranian Journal of Endocrinology and Metabolism. August-September 2014,16(3). 197-205.

  1. Ramezani Tehrani F, Minooee S, Rostami M, Hashemi S, Azizi F. Determination and Comparison of Estimated Menopausal Age Based on Serum Anti-Mullerian Hormone in Women with and without Polycystic Ovarian Syndrome. Iranian Journal of Endocrinology and Metabolism. October-November 2014, 16(4), 283-289.
  2. Hakimi S, Simbar M, Ramezani Tehrani F. Concerns of menopausal women: a phenomenological study in North West Iran. Journal of the Iranian Institute for Health Sciences ( Payesh). 2014; 13, 321-330.
  3. Ramezani Tehrani F1, Behboudi-Gandevani S, Simbar M, Azizi . A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances. J Endocrinol Invest. 2014 Sep 9. [Epub ahead of print]
  4. Samira Behboudi-Gandevani, Somaieh Imani, Lida Moghaddam-Banaem ,Shahla Roudbar-Mohammadi. Can intrauterine contraceptive devices lead to VulvoVaginal Candidiasis (VVC) andanemia in Iranian new users? Sexual & Reproductive Healthcare ■■ (2014)
  5. Tehrani FR, Behboudi-Gandevani S, Ghasemi A, Azizi F. Menopause status as the main factor explaining the gender differences of serum nitric oxide concentrations in middle-aged population. Arch Gynecol Obstet. 2015 Jan;291(1):159-63.
  6. Tehrani FR, Mansournia MA, Solaymani-Dodaran M, Azizi F. Age-specific serum anti-Müllerian hormone levels: estimates from a large population-based sample. Climacteric. 2014 Oct;17(5):591-7.
  7. Amiri P, Amouzegar A, Gharibzadeh S, Kazemian E, Ramezani Tehrani F, Azizi F. Socio-behavioral and reproductive determinants associated with contraceptive method choice among Tehranian women: Tehran Lipid and Glucose Study. Pejouhesh. 2014; 38 (2) :111-119.
  8. Keshavarzi B, Zarnani A, Bozorgmehr M, Tabatabai M, Mirzadegan E, Ramezani Tehrani F, et al . The study of tollerogenic effect of human amniotic epithelial cells co-culture with monocyte derived dendritic cells . Pejouhesh. 2014; 38 (2) :65-78.
  9. Razieh Lotfi , Fahimeh Ramezani Tehrani, * Farideh Yaghmaei , Ebrahim Hajizadeh. Developing a Valid and Reliable Instrument to Predict the Protective Sexual Behaviors in Women at Risk of Human Immunodeficiency Virus. Iran Red Crescent Med J. 2014 September; 16(9): e14682
  10. Soheila Nazarpour, Masome Simbar, Fahimeh Ramezani Tehrani. Factors affecting sexual function during menopause: a review of the literature. Payesh. 2015, 14(1): 41-58.
  11. Keshavarzi B, Zarnani A, Bozorgmehr M, Tabatabai M, Mirzadegan E, Ramezani Tehrani F, et al . The study of tollerogenic effect of human amniotic epithelial cells co-culture with monocyte derived dendritic cells . Pejouhesh. 2014; 38 (2) :65-78.
  12. Rostami Dovom M, Ramezani Tehrani F, Amiri P, Amirshekari G, Farahmand M, Azizi F. Main facilitators of smoking among young males in tehran: tehran lipid and glucose study. Iran Red Crescent Med J. 2014 Sep 5;16(9):e15429.
  13. Rostami Dovom M , Ramezani Tehrani F , Farahmand M , Hashemi S , Rezaee N , Azizi F . Prevalence of Menstrual Disorders and its Related Factors in 18-45 year-old Iranian Women in Four Selected Provinces . Hakim. 2014; 17 (3) :192-199.
  14. Lotfi R, Tehrani FR, Dovom MR, Torkestani F, Abedini M, Sajedinejad S. Development of strategies to reduce cesarean delivery rates in iran 2012-2014: a mixed methods study. Int J Prev Med. 2014 Dec;5(12):1552-66.
  15. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Rostami Dovom M, Noroozzadeh M, Azizi F. The Prevalence of Various Phenotypes of Polycystic Ovary Syndrome: a Community-Based Study in Southwest of Iran. Iranian Journal of Endocrinology and Metabolism. June-July 2014; 16(2): 119-126.
  16. Nazarpour S; Ramezani Tehrani F; Simbar M; Azizi F. Pregnancy outcomes in pregnant women with hypothyroidism (A review Article). IJOGI, Nov 2014l 17(126): 17-26.
  17. Farahmand M, Ramezani Tehrani F, Bahri Khomami M, Azizi F. The association between duration of oral contraceptive pills consumption with metabolic syndrome: tehran lipid and glucose study. Iranian Journal of Doabetes and Metabolism. 2014; 14 (1) :37-46.
  18.  Tehrani, F.RBehboudi-Gandevani, SGhasemi, AAzizi, F. Menopause status as the main factor explaining the gender differences of serum nitric oxide concentrations in middle-aged population. Arch Gynecol Obstet. 2015 Jan;291(1):159-63.
  19. Lotfi R,  Ramezani Tehrani F, Farahnaz Torkestani F, Rostami Dovom M,  Abedini M, Sima Sajedinejad S. Health system management and strategies to decrease elective cesarean section: a qualitative study. January-February 2015; 14(1): 629-636.
  20. Nazarpour  S,  Simbar M, Ramezani Tehrani F. Factors affecting sexual function during menopause: a review of the literature. Payesh. January-February 2015; 14(1): 41-58.
  21. Farahmand M, Ramezani Tehrani F*, Noroozzadeh M, Azizi F.  The relationship between some risk factors of cardiovascular diseases in reproductive age women with duration of oral contraceptive pills use. Feb 2015; 24(4):  242-247.
  22. Peykari N, Eftekhari MB, Tehrani FR, Afzali HM, Hejazi F, Atoofi MK, Qorbani M, Asayesh H, Djalalinia S. Promoting physical activity participation among adolescents: The barriers and the suggestions. Int J Prev Med. 2015 Feb 20;6:12..
  23. Lotfi R, Ramezani Tehrani F, Yaghmaei F, Hajizadeh E. Developing a valid and reliable instrument to predict the protective sexual behaviors in women at risk of human immunodeficiency virus. Iran Red Crescent Med J. 2014 Sep 5;16(9):e14682.
  24. Farahmand M, Amiri P, Ramezani Tehrani F, Momenan AA, Mirmiran P, Azizi F. What are the main barriers to healthy eating among families? A qualitative exploration of perceptions and experiences of Tehranian men. Appetite. 2015 Jun 1;89:291-7.
  25. Daneshian Z, Ramezani Tehrani F, Zarkesh M, Norooz Zadeh M, Mahdian R, Zadeh Vakili A. Antimullerian hormone and its receptor gene expression in prenatally androgenized female rats. Int J Endocrinol Metab. 2015 Jan 30;13(1):e19511.
  26. Minooee S, Ramezani Tehrani F, Mirmiran P, Azizi F. The Association between Birth Weight and Adulthood Body Fat Mass in Women with Poly Cystic Ovary Syndrome. Iranian Journal of Endocrinology and Metabolism. February-March 2015. 16(6);  441-447.
  27. Simbar, MShadipour, MSalamzadeh, JRamezani-Tehrani, FNasiri, N. The combination of "pimpinella anisum, Apium graveolens and Crocus sativus (PAC)" is more effective than "mefenamic acid" on postpartum after-pain. Journal of Herbal Medicine. March 2015; 5(1): 20-25.
  28. Ramezani Tehrani, FMinooee, SRostami, MHashemi, SAzizi, F. Determination and comparison of estimated menopausal age based on serum anti-mullerian hormone in women with and without polycystic ovarian syndrome. Iranian Journal of Endocrinology and Metabolism. October-november 2014. 16(4), 283-289.
  29. Fahimeh Ramezani Tehrani *, Sonia Minooee, Masoumeh Simbar , Fereidoun Azizi. visceral adiposity index (vai), as the best predictor of insulin resistance and metablis syndrome in the women with polycystic ovary syndrome. Inranian journal of Diabetes and Metabolism. 2015. 14(2): 117-128.
  30. Ramezani Tehrani F, Behboudi-Gandevani S, Ghasemi A, Azizi F. Association between serum concentrations of nitric oxide and transition to menopause. Acta Obstet Gynecol Scand. 2015 Jul;94(7):708-714.
  31. Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Ziaei S. Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials.  Iran J Reprod Med. January 2015; 13(1): 1-8.
  32. Khomami MB, Tehrani FR, Hashemi S, Farahmand M, Azizi F. Of PCOS Symptoms, Hirsutism Has the Most Significant Impact on the Quality of Life of Iranian Women. PLoS One. 2015 Apr 15;10(4):e0123608.
  33. Kazemi H, Ramezani Tehrani F, Minooee S, Khalili D, Azizi F. Women self-perception of excess hair growth, as a predictor of clinical hirsutism: a population-based study. Endocrinol Invest. 2015 Aug;38(8):923-8.
  34. Farahmand M, Ramezani Tehrani F, Bahri Khomami M, Noroozzadeh M, Azizi F. Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study. J Endocrinol Invest. 2015 Jul;38(7):761-7.
  35. Noroozzadeh M, Ramezani Tehrani F, Sedaghat K, Godini A, Azizi F. The impact of prenatal exposure to a single dose of testosterone on insulin resistance, glucose tolerance and lipid profile of female rat's offspring in adulthood. J Endocrinol Invest. 2015 May;38(5):489-95.
  36. Nazarpour S, Simbar M, Ramezani Tehrani F, Tohidi M, Alavi Majd H. Study on the Correlation between Serum Androgens and Sexual Function in Post-menopausal Women Iranian Journal of Endocrinology and Metabolism April-May 2015. 17)1(: 13-22.
  37. Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Ziaee S. Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials. Iran J Reprod Med. 2015 Jan;13(1):1-8.
  38. Ehsani B, Moslehi N, Ramezani Tehrani F, Mirmiran P, Azizi F. Relationship between Dietary Pattern and Cardiometabolic Risk Factors in Women with PCOS. Iranian Journal of Endocrinology and Metabolism. 2015; 17 (1) :33-43.
  39. Djalalinia S, Ramezani Tehrani F, Malekafzali H, Hashemi Z, Peykari N. A youth-led reproductive health program in a university setting. Med J Islam Repub Iran. 2015; 29 (0) :210-0
  40. Nazarpour S, Simbar M, Ramezani Tehrani F. Effects of the severity of menopausal symptoms on sexual function in postmenopausal women. The Journal of Qazvin University of Medical Sciences. 2015; 19 (4) :63-54
  41. Nazarpour S, Simbar M, Ramezani Tehrani F. androgens and sexual function during menopause. urmia medical journal. 2015; 26 (2) :135-147
  42. Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani A. Comparison of energy-restricted high protein (HP) with standard-protein (SP) diets in women with polycystic ovary syndrome. MEDICAL SCIENCES. 2015; 25 (2) :95-104
  43. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Khalili D, Hosseinpanah F, Azizi F. The Prevalence of Menstrual Disorders in Reproductive Aged Women and its Related Factors. Iranian Journal of Endocrinology and Metabolism. 2015; 17 (2) :105-112.
  44. Ramezani Tehrani F. Polycystic Ovary Syndrome: An Apparently Simple yet Challenging Diagnosis.  Int J Endocrinol Metab 2015 July; 13(3): e28557.
  45. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Exercise and sexual dysfunction among postmenopausal women in Iran. Scientific Journal of School of Public Health and Institute of Public Health Research. Spring 2015; 13(1): 17-32.
  46. Kazemijaliseh H, Ramezani Tehrani F1, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Azizi F. The Prevalence and Causes of Primary Infertility in Iran: A Population-Based Study. Glob J Health Sci. 2015 Apr 19;7(6):45001.
  47. Farahmand M, Ramezani Tehrani F, Rostami Dovom M, Hashemi S, Azizi F. The impact of oral contraceptives on cardiometabolic parameters. J Endocrinol Invest. 2016 Mar;39(3):277-83.
  48. Nazarpour S, Ramezani Tehrani F, Simbar M, Azizi F. Thyroid autoantibodies and the effect on pregnancy outcomes. J Obstet Gynaecol. 2016;36(1):3-9.
  49. Farahmand M, Ramezani Tehrani F, Rostami Dovom M, Hashemi S, Azizi F. The impact of oral contraceptives on cardiometabolic parameters. J Endocrinol Invest. 2016 Mar;39(3):277-83.
  50. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Alavi Majd H , Azizi F. Mimetical Signs and Symptoms of Thyroid Disorders in Healthy Pregnant Women, a Population Based Study. Iranian Journal of Endocrinology and Metabolism. Aug-Sep 2015; Vol 17 No.3: 181-189.
  51. Ramezani Tehrani F, Montazeri SA, Hosseinpanah F, Cheraghi L, Erfani H, Tohidi M, Azizi F. Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study. PLoS One. 2015 Sep 11;10(9):e0137609.
  52. Depmann M, Broer SL, van der Schouw YT, Tehrani FR, Eijkemans MJ, Mol BW, Broekmans FJ. Can we predict age at natural menopause using ovarian reserve tests or mother's age at menopause? A systematic literature review. Menopause. 2016 Feb;23(2):224-32.
  53. Maryam Rostami, Fahimeh Ramezani Tehrani*, Masoomeh Simbar , Farhad Hossein Panah, Hamid Alavi Majd. Prevalence of Vitamin D deficiency and Affecting factors Among Pregnant Women in the First Trimester in Masjed Soleimam,Iran IJOGI, Vol. 18, No. 164, pp. 1-10, Sep 2015.
  54. Nazarpour S, Ramezani Tehrani F, Simbar M, Azizi F. Thyroid dysfunction and pregnancy outcomes. Iran J Reprod Med. 2015 Jul;13(7):387-96. Review.
  55. Nazarpour S, Tehrani FR, Simbar M, Tohidi M, AlaviMajd H, Azizi F. Comparison of universal screening with targeted high-risk case finding for diagnosis of thyroid disorders. Eur J Endocrinol. 2016 Jan;174(1):77-83.
  56. Ehsani B, Moslehi N, Mirmiran P, Ramezani Tehrani F, Tahmasebinejad Z, Azizi F. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome. Clin Nutr. 2015 Nov 25. pii: S0261-5614(15)00261-7.
  57. Minooee S, Ramezani Tehrani F, Azizi F. Hirsutism region and the likelihood of metabolic syndrome: is there a link? Endocrine. 2016 Aug;53(2):607-9.
  58. Lotfi R, Ramezani Tehrani F, Salehifar D, Dworkin SL. Erratum to: Predictors of Condom Use Among Iranian Women at Risk of HIV. Arch Sex Behav. 2016 Feb;45(2):439.
  59. Lotfi R, Ramezani Tehrani F, Salehifar D, Dworkin SL. Predictors of Condom Use Among Iranian Women at Risk of HIV. Arch Sex Behav. 2016 Feb; 45(2): 429-37.
  60. Hakimi S, Simbar M, Ramezani Tehrani F, Zaiery F, Khatami S. Women's perspectives toward menopause: A phenomenological study in Iran. J Women Aging. 2016;28(1):80-9.
  61. Nazarpour S, Simbar M,* Ramezani Tehrani F, Alavi Majd H. Sexual Function and Exercise in Postmenopausal Women Residing in Chalous and Nowshahr, Northern Iran. Iran Red Crescent Med J. 2016 Jan 20;18(5):e30120.
  62. Nasiri-Amiri F, Ramezani Tehrani F, Simbar M*, Montazeri A, Mohammadpour RA. Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties. Qual Life Res. 2016 Jul;25(7):1791-801.
  63. Ramezani Tehrani F, Mansournia MA, Solaymani-Dodaran M, Steyerberg E, Azizi F. Flexible parametric survival models built on age-specific antimu¨llerian hormone percentiles are better predictors of menopause. Menopause. 2016 Jun;23(6):676-81.
  64. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. The impact of a sexual enhancement program on the sexual function of postmenopausal women. Climacteric. 2016 Oct;19(5):506-11.
  65. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Azizi F. Tehran thyroid and pregnancy study: objectives and study protocol. Int J Endocrinol Metab. 2016 Jan 30;14(1):e33477.
  66. Behboudi-Gandevani S,  Ramezani Tehrani F*,  Rostami Dovom M,  Farahmand M,  Bahri Khomami M,  Noroozzadeh M,  Kabir A,  Azizi F. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol. 2016;32(5):343-53.
  67. Behboudi-Gandevani S, Moghaddam-Banaem L, Shahbazi S, Ekhtesari F. Maternal rare inherited bleeding disorders and neonatal complications. J Obstet Gynaecol Res. 2016 Feb;42(2):172-7. (IF=1.072)
  68. Abdi F, Mobedi PharmD H, Mosaffa N, Dolatian M, Ramezani Tehrani F. Hormone Therapy for Relieving Postmenopausal Vasomotor Symptoms: A Systematic Review. Arch Iran Med. 2016 Feb;19(2):141-6.
  69. Hajizadeh S, Tehrani FR, Simbar M, Farzadfar F. Effects of Recruiting Midwives into a Family Physician Program on Women's Awareness and Preference for Mode of Delivery and Caesarean Section Rates in Rural Areas of Kurdistan. PLoS One. 2016 Apr 8;11(4):e0151268.
  70. Hajizadeh S, Ramezani Tehrani F, Simbar M, Farzadfar F. Effects of Recruiting Midwives into a Family Physician Program on the Indices of Maternal Health Program in the Rural Areas of Kurdistan. Glob J Health Sci. 2016 Mar 1;8(11):53539.
  71. Tehrani FR, Zarkesh M, Tohidi M, Azizi F, Zadeh-Vakili A. Is the association between insulin resistance and diabetogenic haematopoietically expressed homeobox (HHEX) polymorphism (rs1111875) affected by polycystic ovary syndrome status? Reprod Fertil Dev. 2017 Apr;29(4):670-678.
  72. Amini L., Tehranian N.*, Movahedin M., Ramezani Tehrani F. Effect of calligonum comosum on ovarian histology of polycystic ovary mouse model. Journal of Medicinal Plants;   december 2015; 14(56): 115-122.
  73. Amiri, M., Mirmiran, P., Ramezani Tehrani, F. Effect of interventions based on lifestyle modification on clinical, hormonal and metabolic findings in the patients with polycystic ovary syndrome: A systematic review. Iranian Journal of Endocrinology and Metabolism. 2016, 17(6): 489-500.
  74. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Sexual dysfunction and the underlying medical problems in post-menopausal women. Tehran Univ Med J. 2016; 73 (11) :798-811.
  75. Masoumeh Simbar; Fatemeh Rahmanian; Fahimeh Ramezani Tehrani. Explaining the experiences and perceptions of gynecologists and midwives about virginity examination and it’s outcomes: A qualitative Study. The Iranian Journal of Obstetrics, Gynaecology and Infertility. Autumn 2015; 18(173): 1-40.
  76. Gohari MR, Ramezani Tehrani F, Chenouri SH, Solaymani-Dodaran M, Azizi F. Individualized predictions of time to menopause using multiple measurements of antimu¨llerian hormone. Menopause. 2016 Aug;23(8):839-45.
  77. Abdi F, Mobedi H, Mosaffa N,. Dolatian M & Ramezani Tehrani F. Effects of hormone replacement therapy on immunological factors in the postmenopausal period. Climacteric, 2016; 19(3): 234–239.
  78. Abdi F, Kazemi F, Ramezani Tehrani F, Roozbeh N. Protocol for systematic review and meta-analysis: hop (Humulus lupulus L.) for menopausal vasomotor symptoms. BMJ Open. 2016 Apr 22;6(4):e010734.
  79. Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani AR, Moslehi N. Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls. Glob J Health Sci. 2016 Feb 2;8(9):54801.
  80. Bahri Khomami M, Ramezani Tehrani F, Hashemi S, Mohammadi N, Rashidi H, Azizi F. Does the risk of metabolic disorders increase among women with polycystic ovary morphology? A population-based study. Hum Reprod. 2016 Jun;31(6):1339-46.
  81. Noroozzadeh M, Ramezani Tehrani F, Zadeh Vakili A, Piryaei A, Azizi F. The effect of intrauterine injection of androgen on reproductive system and hormonal changes in adult female rat's offspring. Iranian Journal of Physiology and Pharmacology. Summer 2015; 1(2): 68-76.
  82. Ramezani Tehrani F, Bahri Khomami M, Amouzegar A, Azizi F Thyroperoxidase antibodies and polycystic ovarian morphology. Int J Gynaecol Obstet. 2016 May 4. pii: S0020-7292(16)30112-6.
  83. Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani A R, Moslehi N. Factors Influencing Physical Activity in Women with Polycystic Ovary Syndrome in Comparison to Eumenorrheic Non Hirsute Women. Global Journal of Health Science. Feb 2016; 8(10):  127-134.
  84. Ramezani Tehrani F, Montazeri SA, Khalili D, Cheraghi L, Broekmans FJ, Momenan AA, de Kat AC, Azizi F. Age-specific anti-Müllerian hormone and electrocardiographic silent coronary artery disease. Climacteric. 2016 Aug;19(4):344-8.
  85. Minooee S, Ramezani Tehrani F, Mirmiran P, Azizi F. Low birth weight may increase body fat mass in adult women with polycystic ovarian syndrome. Int J Reprod BioMed.  May 2016; 14(5): 335-340.
  86. Nazarpour S, Ramezani Tehrani F*, Simbar M, Tohidi M, Azizi F. Thyroid and Pregnancy in Tehran, Iran: Objectives and Study Protocol. Int J Endocrinol Metab. 2016 Jan 30;14(1):e33477.
  87. Salehi Jahromi M, Ramezani Tehrani F, Zadeh-Vakili A. The Effects of Prenatal Excess Androgens Exposure on the Gene Expression. Iranian Journal of Endocrinology and Metabolism. 2016; 18 (4) :303-313
  88. Rezayat F, Hajiaghayi M, Ramezani Tehrani F*, Mosaffa N. Increase Risk of Ovarian and Breast Cancers in Women with PolyCystic Ovarian Syndrome: a Review. Iranian Journal of Endocrinology and Metabolism. April-May 2016; 18 (1): 54-62.
  89. Nazarpour S, Ramezani Tehrani  F, Simbar M, Tohidi M. Comparison of universal screening with targeted high-risk case finding of thyroid disorders in pregnant women. The Quarterly journal of School of Medicine, Shahid Beheshti University of Medical Sciences. 2015; 39(3): 145-151.
  90. Hajizadeh Sh, Ramezani Tehrani F, Simbar M, Farzadfar F. Factors affecting pregnancy, postpartum and neonatal complications in rural areas of Kurdistan Province, Iran. Scientific Journal of School of Public Health and Institute of Public Health Research. Spring 2015; 13(3): 19-36.
  91. Hashemi S, Ramezani Tehrani F, * Mohammadi N, Rostami Dovom M, Torkestani F, Simbar M, & Azizi F. Comparison of Metabolic and Hormonal Profiles of Women With and Without Premenstrual Syndrome: A Community Based Cross-Sectional Study. International Journal of Endocrinology and Metabolism. 14(2): e28422.
  92. Rashidi H, Sharif Najafi A, Kaykhaei MA, Latifi SM, Ramezani Tehrani F, Shahbazian H. Association of thyroid stimulating hormone in women with poly cystic ovary syndrome and non poly cystic ovary syndrome with insulin resistance. International Journal Of Pharmacy & Technology. June 2016; 8(2): 11634-11642.
  93. Jahromi MS, Tehrani FR, Noroozzadeh M, Zarkesh M1, Ghasemi A, Zadeh-Vakili A. Elevated expression of steroidogenesis pathway genes; CYP17, GATA-6 and StAR in prenatally androgenized rats Gene. 2016 Nov 15;593(1):167-71.
  94. Behboudi-Gandevani S1, Ramezani Tehrani F2, Cheraghi L3, Azizi F. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol. 2016 Aug 9;205:110-114.
  95. Salehifar D, Lotfi R, Ramezani Tehrani F. The Comparative Study of Depression in Women with Polycystic Ovary Syndrome and Control Group. Iranian Journal of Endocrinology and Metabolism. Aug-Sep 2016; 18(3): 180-186.
  96. Hajiaghayi M, Rezayat F, Ghasemi N, Mesdaghi M, Soleymanian A, Mosaffa N, RamezaniTehrani F. The Study of cell Proliferation, TNF- Cytokine Production and Expression of CD8 Marker in Peripheral Blood Lymphocytes of Women with Polycystic Ovary Syndrome (PCOS) by co-culture with Ovarian Tumor Cell Lines (SKOV3,A2780). Iranian Journal of Endocrinology and Metabolism. Aug-Sep 2016; 18(3): 180-186.
  97. Rezayat F, Hajiaghaei M, Mosaffa N, Ramezani Tehrani F, Mesdaghi M. The Study of Peripheral Blood Mononuclear Cells Activity of Women with Polycystic Ovary Syndrome (PCOS) by coculture with Breast Cancer Cell Lines Compared with the Healthy Controls. Iranian Journal of Endocrinology and Metabolism. June-July 2016; 18(2): 120-127.
  98. Ghasemi N, Ramezani Tehrani F, Mosaffa N. Effects of Nulliparity and Multiparity on Probability of Breast Tumor Incidences: A review. Iranian Journal of Endocrinology and Metabolism. June-July 2016; 18(2): 128-134.
  99. Noroozzadeh M, Tehrani FR, Mobarakabadi SS, Farahmand M, Dovom MR. Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study. Int J Impot Res. 2017 Jan;29(1):1-6.
  100. Nazarpour S, Simbar M, Tehrani FR. Factors affecting sexual function in menopause: A review article. Taiwan J Obstet Gynecol. 2016 Aug;55(4):480-7.
  101. Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani AR. Comparison of the Association of Excess Weight on Health Related Quality of Life of Women with Polycystic Ovary Syndrome: An Age- and BMI-Matched Case Control Study. PLoS One. 2016 Oct 13;11(10):e0162911.
  102. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M4 Alavi Majd H, Azizi F. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Eur J Endocrinol. 2017 Feb;176(2):253-265.
  103. Farahmand M, Tehrani FR, Dovom MR, Azizi F. Menarcheal Age and Risk of Type 2 Diabetes: A Community-Based Cohort Study. J Clin Res Pediatr Endocrinol. 2017 Jun 1;9(2):156-162.
  104. Rostami Dovom M, Ramezani Tehrani F, Djalalinia SH, Cheraghi L, Behboudi Gandavani S, Azizi F. menstrual cycle irregularity and metabolic disorders: a population-based prospective study. PLoS One. 2016 Dec 16;11(12):e0168402.
  105.  Rostami Dovom M, Ramezani Tehrani F*,  Nazeri P,  Alamdari SH, Azzizi F. Using a Scientific Map to Compare Scientific Publications on Poly Cystic Ovary Syndrome in Iran, Middle East and Other Countries. Iranian Journal of Endocrinology and Metabolism. 2016; 18 (4) :287-296.
  106. Ghasemi N, Hajiaghayi M, Rezayat F, Mesdaghi M, Mosaffa N, Ramezani Tehran F. Expression of CD8 marker and proliferation of peripheral blood lymphocyte of multiparous women by Co-culture with breast tumor cell, MDA-231 and MCF-7 lines and comparison with nulliparous women. The Iranian Journal of Obstetrics, Gynecology and Infertility. Summer 2016; 19(20): 8-18.
  107. Hashemi  S, Ramezani Tehrani F, Bahry Khomami M, Azizi F. In Vitro Diagnostic Criterion of Androgen Excess in Polycystic Ovary Syndrome: A Community Based Study on Iranian Reproductive Aged Women. Medical Journal of Tabriz University of Medical Sciences and Health Services. Oct. – Nov. 2016; 38(4): 84-89.
  108. Noroozzadeh M, Ramezani Tehrani F, Bahri Khomami M, Azizi F. A Comparison of Sexual Function in Women with Polycystic Ovary Syndrome (PCOS) Whose Mothers Had PCOS During Their Pregnancy Period with Those Without PCOS. Arch Sex Behav. 2017 Oct;46(7):2033-2042.
  109. Salehi Jahromi, M.Ramezani Tehrani, F, Zadeh-Vakili, A*. The effects of prenatal excess androgens exposure on the gene expression. I ranian Journal of Endocrinology and Metabolism. Dec 2016; 18(4): 303-313.
  110. Nazarpour S8, Simbar M, Ramezani Tehrani F, Alavi Majd H. Relationship between Sexual Function and Quality of Life in Post-menopausal Women. J Mazandaran Univ Med Sci. 2016; 26(143): 88-98.
  111. Abdi F, Ramezani Tehrani F, Mobedi H, Dolatian M, Mosaffa N. Nanomedicine Approaches for Treatment of Menopausal Symptoms. J Menopausal Med. 2016 Dec;22(3):127-128.
  112. Abdi F, Mobedi H, Bayat F, Mosaffa N, Dolatian M, RamezaniTehrani F*. The Effects of Transdermal Estrogen Delivery on Bone Mineral Density in Postmenopausal Women: A Meta-analysis.  Iranian Journal of Pharmaceutical Research. 2017; 16 (1): 380-389.
  113. Salehi Jahromi M, Ramezani Tehrani F, Hill JW, Noroozzadeh M, Zarkesh M, Ghasemi A, Zadeh-Vakili A*. Alteration in follistatin gene expression detected in prenatally androgenized rats. Gynecol Endocrinol. 2017 Jun;33(6):433-437.
  114. Daneshpour MS, Fallah MS, Sedaghati-Khayat B, Guity K, Khalili D, Hedayati M, Ebrahimi A, Hajsheikholeslami F, Mirmiran P, Ramezani Tehrani F, Momenan AA, Ghanbarian A, Amouzegar A, Amiri P, Azizi F*. Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS). JMIR Res Protoc. 2017 Feb 23;6(2):e28.
  115. Minooee S, Ramezani Tehrani F*, Tohidi M, Azizi F. Role of androgen ratios in the prediction of the metabolic phenotype in polycystic ovary syndrome. Int J Gynaecol Obstet. 2017 May;137(2):110-115..
  116. Minooee S, Ramezani Tehrani F, Rahmati M, Mansournia MA, Azizi F. Diabetes incidence and influencing factors in women with and without gestational diabetes mellitus: A 15year population-based follow-up cohort study. Diabetes Res Clin Pract. 2017 Apr 8;128:24-31. (IF= 3.045)
  117. Simbar M*, Aarabi Z, Keshavarz Z, Ramezani-Tehrani F, Baghestani AR. "Promotion of physical activity of adolescents by skill-based health education". Health Education. 2017, 117(2): 207-214.
  118. Behboudi-Gandevani S, Ramezani Tehrani F*, Cheraghi L, Noroozzadeh M, Farahmand M, Azizi F. Trends of contraception use among married reproductive age women: Tehran lipid and glucose cohort study 2002-2011. Sex Reprod Healthc. 2017 Jun;12:116-122.
  119. Amiri M, Ramezani Tehrani F*, Nahidi F, Kabir A, Azizi F, Carmina E. Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism clinical and experimental. Aug 2017; 73: 22-35. (IF= 4.375)
  120. Rostami M, Ramezani Tehrani F, Simbar M, Hosseinpanah F, Alavi Majd H. Rationale and Design of Khuzestan Vitamin D Deficiency Screening Program in Pregnancy: A Stratified Randomized Vitamin D Supplementation Controlled Trial. JMIR Res Protoc. 2017 Apr 7;6(4):e54.
  121. Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F. The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Invest. 2017 Aug;40(8):859-866. IF=1.994
  122. Amiri M, Ramezani Tehrani F, Nahidi F, Bidhendi Yarandi R, Behboudi-Gandevani S, Azizi F. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: a systematic review and meta-regression analysis. Clin Endocrinol (Oxf). 2017 Sep;87(3):217-230.
  123. Nazarpour S1, Simbar M2, Ramezani Tehrani F3, Alavi Majd H. Effects of Sex Education and Kegel Exercises on the Sexual Function of Postmenopausal Women: A Randomized Clinical Trial. J Sex Med. 2017 Jul;14(7):959-967.
  124. Moslehi N, Mirmiran P, Tehrani FR, Azizi F. Current Evidence on Associations of Nutritional Factors with Ovarian Reserve and Timing of Menopause: A Systematic Review. Adv Nutr. 2017 Jul 14;8(4):597-612. (IF= 5.233)
  125. M. Depmann, M.J.C. Eijkemans, S.L. Broer, A. de Kat, F. Ramezani Tehrani, M. olaymani Dodaran, F. Azizi, M. Solaymani, J.F. Randolph JR, S.D. Harlow, E.W. Freeman, M.D. Sammel, M. Wellons, W.M.M. Verschuren, Y.T. van der Schouw, B.W. Mol, F.J.M. Broekmans. How well does AMH relate to the timing of menopause? Results of an individual patient data meta-analysis. Maturitas. June 2017; 100: 201. (IF= 3.255)
  126. Ramezani Tehrani F, Mansournia MA, Solaymani-Dodaran M, Minooee S, Azizi F. Serum variations of anti-mullerian hormone and total testosterone with aging in healthy adult Iranian men: A population-based study. PLoS One. 2017 Jul 17;12(7):e0179634. (IF= 2.806)
  127. Farahmand M, Ramezani Tehrani F, Khalili D, Amin G, Negarandeh R. Factors associated with the severity of premenstrual syndrome among Iranian college students. J Obstet Gynaecol Res. 2017 Nov;43(11):1726-1731.(IF=1.086)
  128. Simbar M*, Aarabi Z, Keshavarz Z, Ramezani Tehrani F, Baghestani A.R. Promotion of physical activity of adolescents by skill-based health education.  Health Education. 2017; 117(2): 207-214.
  129. Amiri M, Nahidi F, Khalili D, Bidhendi-Yarandi R, Ramezani Tehrani F. Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol. JMIR Res Protoc. 2017 Sep 29;6(9):e191.
  130. Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Noroozzadeh M, Farahmand M, Rostami Dovom M, Ramezani Tehrani F. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018 Feb;88(2):169-184. (IF=3.327)
  131. Minooee S, Ramezani Tehrani F, Rahmati M, Mansournia MA, Azizi F. Dyslipidemia incidence and the trend of lipid parameters changes in women with history of gestational diabetes: a 15-year follow-up study. Endocrine. 2017 Nov;58(2):228-235.
  132. Kazemijaliseh H, Ramezani Tehrani F*, Behboudi-Gandevani S, Khalili D, Hosseinpanah F, Azizi F. A Population-Based Study of the Prevalence of Abnormal Uterine Bleeding and its Related Factors among Iranian Reproductive-Age Women: An Updated Data. Arch Iran Med. 2017 Sep;20(9):558-563.
  133.  Behboudi-Gandevani S. Ramezani Tehrani F Rostami Dovoom M, Azizi F. Population policies and contraception use behavior: Tehran Lipid and Glucose Study. Hakim Health Sys Res 2016; 19(1): 25- 32 .
  134. Noroozzadeh M, Ramezani Tehrani F, Zadeh-Vakili A, Piryaei A, Ghasemi A, Azizi F. The effects of testosterone intrauterine disturbance on sperm quality and testis tissue in male rat's offspring after puberty. Iran South Med J. 2016; 19 (3) :372-384
  135. Hakimi S, Nazarpour S, Ramezani Tehrani F, Simbar M, Zaiery F. Women's Experiences about Menopause and Related Factors. Iranian Journal of Endocrinology and Metabolism. 2017; 19 (3) :185-193.

 

  1. Farahmand M, Ramezani Tehrani F*, Bahri Khomami M, Azizi F. Adverse Cardiometabolic Effect in Bilateral/Unilateral Oophorectomy Versus Natural Menopause: Results of Over a Decade Follow-up Among Iranian Women. Arch Iran Med. December 2017;20(12):734-739. (IF=1.2)
  2. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Quality of life and sexual function in postmenopausal women. J Women Aging. 2018 Jul-Aug;30(4):299-309 (IF= 0.658)
  3. Noroozzadeh M, Behboudi-Gandevani S, Zadeh-Vakili A, Tehrani FR. Hormone-induced rat model of polycystic ovary syndrome: A systematic review. Life Sci. 2017 Dec 15;191:259-272.
  4.  Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Minooee S, Rahmati M, Azizi F. Effects of Levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies. J Clin Endocrinol Metab. 2017 Nov 6. doi: 10.1210/jc.2017-01850. [Epub ahead of print]. (IF=5.455)
  5. Nasiri Amiri F, Ramezani Tehrani F, Esmailzadeh S, Tohidi M, Azizi F, Basirat Z. Sexual function in women with polycystic ovary syndrome and their hormonal and clinical correlations. Int J Impot Res. Int J Impot Res. 2018 Apr;30(2):54-61.  (IF=1.293)Q2
  6. Nazarpour S, Simbar M, Tehrani FR, Majd HA. The relationship between menopausal symptoms and sexual function. Women Health. 2017 Dec 14. doi: 10.1080/03630242.2017.1414100. [Epub ahead of print].
  7. Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Cheraghi L, Azizi F. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril. 2017 Dec;108(6):1078-1084.
  8. Simbar M, Nazarpour S, Mirzababaie M, EmamHadi MA, Tehrani FR, Majd HA. Quality of Life and Body Image of Individuals with Gender Dysphoria. J Sex Marital Ther. 2018 Jan 3:0. doi: 10.1080/0092623X.2017.1419392. [Epub ahead of print].
  9. Zeydabadi Nejad S, Ramezani Tehrani F, Zadeh-Vakili A. The Role of Kisspeptin in Female Reproduction. Int J Endocrinol Metab. 2017 Apr 22;15(3):e44337. (pubmed)
  10. Hatami H, Montazeri SA, Hashemi N, Ramezani Tehrani F. Optimal Cutoff Points for Anthropometric Variables to Predict Insulin Resistance in Polycystic Ovary Syndrome. Int J Endocrinol Metab. 2017 Jul 30;15(4):e12353. (pubmed)
  11. Nazarpour S, Ramezani Tehrani F, Simbar M, Minooee S, Rahmati M, Mansournia MA, Azizi F. Establishment of trimester-specific reference range for thyroid hormones during pregnancy. Clin Biochem. 2018 Mar;53:49-54

 

  1. A Mansournia M, Minooee S, Ramezani Tehrani F, Rahmati M, Azizi F. Authors' reply. Climacteric. 2018 Apr;21(2):196.

 

  1. Amiri M, Kabir A, Nahidi F, Shekofteh M, Ramezani Tehrani F*. Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Contracept Reprod Health Care. 2018 Feb 192018 Feb 19, 23(1): 67-77. (IF=1.627)
  2. Salehi Jahromi M, Zadeh-Vakili A, Ramezani Tehrani F*. The consequences of prenatal excess androgen exposure in anatomy of the reproductive system and physiology. Iranian journal of Endocrinology and Metabolism. December-January 2018; 19(5); 357-369. (pubmed)
  3. Hajizadeh Sh , Ramezani Tehrani  F*, Simbar M , Farzadfar  F*. Effects of recruiting midwives into family physician program on the per-centage of low birth weight (LBW) infants in rural areas of Kurdistan. Med J Islam Repub Iran.  Dec 2017; 31(1): 1-8. (pubmed)
  4. Minooee S, Ramezani Tehrani F. Rahmati, M., Mansournia M.A, Azizi, F. Prediction of age at menopause in women with polycystic ovary syndrome. Climacteric. Jan 2018; 21(1): 29-34. (IF=2.271)

 

  1. Amiri M, Nahidi F, Khalili D, Bidhendi-Yarandi R, Ramezani Tehrani F*. Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol. JMIR Res Protoc. 2017 Sep; 6(9): e191.
  2. Sareh Z, Azita Zadeh V, Mahsa N, Razieh Bidhendi Y, Asghar G, Amir RA, Ramezani Tehrani F*. Prenatal Exposure of Kisspeptin Antagonist on the GonadotropinReleasing Hormone (GnRH) Expression in Rat Model of Polycystic Ovary Syndrome. J Fertil In Vitro IVF Worldw Reprod Med Genet Stem Cell Biol. 2017;  5(3): 1-8
  3. Moslehi N, Shab-Bidar S, Ramezani Tehrani F*, Mirmiran P*, Azizi F. Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis. Menopause. 2018 Sep;25(9):1046-1055. (IF=2.733) Q1
  4. Hatami H, Parizadeh D, Bidhendi Yarandi R, Tohidi M, Ramezani Tehrani F*. Endogenous testosterone does not improve prediction of incident cardiovascular disease in a community-based cohort of adult men: results from the Tehran Lipid and Glucose Study. Aging Male. 2018 Apr 27:1-8. doi: 10.1080/13685538.2018.1466876. [Epub ahead of print].(IF=2.108)Q2
  5. Amiri M, Ramezani Tehrani F*, Nahidi F, Kabir A, Azizi F. Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. JMIR Res Protoc. 2018 Apr 25;7(4):e113. (pubmed)

 

  1. Jahromi MS, Hill JW, Tehrani FR, Zadeh-Vakili A*. Hypomethylation of specific CpG sites in the promoter region of steroidogeneic genes (GATA6 and StAR) in prenatally androgenized rats. Life Sci. 2018 May 30. pii: S0024-3205(18)30320-5. doi: 10.1016/j.lfs.2018.05.052. [Epub ahead of print]. (IF=2.936) Q1
  2. Rostami M, Ramezani Tehrani F*, Simbar M, Bidhendi Yarandi R, Minooee S, Hollis BW, Hosseinpanah F. Effectiveness of prenatal vitamin D deficiency screening and treatment program: a stratified randomized field trial. J Clin Endocrinol Metab. 2018 Aug 1;103(8):2936-2948.

 

  1. Sajadi M, Noroozzadeh M, Bagheripour F, Ramezani Tehrani F. Contractions in the Isolated Uterus of a Rat Model of Polycystic Ovary Syndrome Compared to Controls in Adulthood. Int J Endocrinol Metab. 2018 Apr 18;16(2):e63135. (pubmed) Q3
  2. Nasiri-Amiri F, Ramezani Tehrani F*, Simbar M, Montazeri A, Mohammadpour RA. The Polycystic Ovary Syndrome Health-Related Quality-of-Life Questionnaire: Confirmatory Factor Analysis. Int J Endocrinol Metab. 2018 Feb 3;16(2):e12400. (pubmed) Q3
  3. Nazarpour S, Simbar M, Majd HA, Tehrani FR. Beneficial effects of pelvic floor muscle exercises on sexual function among postmenopausal women: a randomised clinical trial. Sex Health. 2018 Jul 27. doi: 10.1071/SH17203. [Epub ahead of print].

 

  1. Salehi Jahromi M, Hill JW, Ramezani Tehrani F, Zadeh-Vakili A*. Hypomethylation of specific CpG sites in the promoter region of steroidogeneic genes (GATA6 and StAR) in prenatally androgenized rats. Life Sci. 2018 Aug 15;207:105-109.
  2. Depmann M, Eijkemans MJC, Broer SL, Tehrani FR, Solaymani-Dodaran M, Azizi F, Lambalk CB, Randolph JF Jr, Harlow SD, Freeman EW, Sammel MD, Verschuren WMM, van der Schouw YT, Mol BW, Broekmans FJM. Does AMH relate to timing of menopause? Results of an Individual Patient Data meta- analysis. J Clin Endocrinol Metab. 2018 Jul 18. doi: 10.1210/jc.2018-00724. [Epub ahead of print]

 

  1. Ramezani Tehrani F, Minooee S, Rostami M, Bidhendi Yarandi R, Hosseinpanah F. Response to Letter to the Editor (Effectiveness of Prenatal Vitamin D Deficiency Screening and Treatment Program: A Stratified Randomized Field Trial). J Clin Endocrinol Metab. 2018 Sep 6. doi: 10.1210/jc.2018-01799. [Epub ahead of print] No abstract available. (IF=5.789) Q1
  2. Moslehi N, Shab-Bidar S, Ramezani Tehrani F*, Mirmiran P, Azizi F. Systematic Review of the Association between BMI and Antimullerian Hormone (AMH) Levels in Reproductive Aged Women.. Iranian Journal of Endocrinology and Metabolism. June-july 2018; 20(2): 89-101. Scopus
  3. Amiri M, Bidhendi Yarandi R, Nahidi F, Tohidi M, Ramezani Tehrani F. The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2018 Sep 19. doi: 10.1111/cen.13858. [Epub ahead of print].
  4. Nazarpour S, Ramezani Tehrani F, Rahmati M, Minooee S, Simbar M, Noroozzadeh M, Azizi F. Validation of Billewicz Scoring System for Detection of Overt Hypothyroidism During Pregnancy. Int J Endocrinol Metab. 2018 Jul 7;16(3):e64249. Pubmed (Q3)
  5. Tehranian N, Hosseini M, Ramezani-Tehrani F, Yousefi S. Association of serum ghrelin with weight gain during pregnancy in overweight and normal women. J Endocrinol Invest. 2018 Nov 21. doi: 10.1007/s40618-018-0986-x. [Epub ahead of print] (IF=3.166) Q2
  6. Nazarpour S, Ramezani Tehrani F*, Simbar M, Rahmati M, Azizi F. Frequency of positive thyroid peroxidase antibody and its related factors during pregnancy in pregnant women referring to the centers under coverage of Shahid Beheshti University of Medical Sciences 2013-2016. IJOGI. Sep 2018;  21(7): 20-28.
  7. Behboudi-Gandevani S, Ramezani Tehrani F, Hosseinpanah F, Khalili D, Cheraghi L, Kazemijaliseh H, Azizi F. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study. Fertil Steril. 2018 Dec;110(7):1377-1386. (IF=4.803) Q1
  8.  

 

 

 

 

Research Projects:

 

  1. Reproductive health needs of university students, 1991-2001

 

  1. A comparative study on early complication  of two different methods of tubal ligation by laparoscopy(Filishi clip or Bipolar Electro coagulation), 1996-1999

 

  1. Prevalence of infertility in Iran, 1997-1999

 

  1. Unwanted pregnancy and its effective factors, 1997-1999

 

  1. Reproductive history of Iranian women,1997-2000(with UNFPA)

 

  1. Postpartum counseling of family planning,1997-2001

 

  1. Premarital counseling of STDs/HIV/AIDS, 1997-2001(with UNFPA)

 

  1. Comparison of thyroid function tests in vaginal delivery versus cesarean section,1999-2000

 

  1. A comparative study of side effects and accessibility of two different kinds of inject able contraception (DMPA-CYCLOFEM),1999-2001

 

  1. A survey on early and late complication of menopause,1999-2001

 

  1. A comparative study of K.A.P of girls about adolescence Reproductive Health in three different groups(counseling through parents or teachers and no counseling), 1999-2002

 

  1. Thyroid function tests in preeclamptic pregnancy, 2000-2001

 

  1. Promotion of reproductive health among youth, 2001-2004

 

  1. Promotion of sexual reproductive health of university students, 2001-2005 (with UNFPA)

 

  1. Evaluation of pre marriage counseling programs, 2002-2003(with UNFPA)

 

  1. Study on reasons for couples who change their methods, 2002-2004

 

  1. Survey of reproductive health needs of men for family planning and maternal health, 2002-2004(with UNFPA)

 

  1. Follow up survey of women and men using contraception and their reasons for discontinuation, 2002 -2004(with UNFPA)

 

  1. Reproductive health knowledge, attitude and practice of middle and late unmarried adolescence boys in context of prevailing psychosocial condition, 2002-2004 (With WHO)

 

  1. An interventional study for elimination of HIV/AIDS in high risk selected area of Iran, 2002 -2005 (Collaboration research project WHO)

 

  1. A qualitative research study on violence against women, 2002 in progress (Collaboration research project UNFPA)

 

  1. A multidisciplinary approach for promotion of reproductive health among youth, 2003-2005 (Collaboration research project WHO)

 

  1. A quantitative study of high risk behavior in regard to HIV/AIDS among adolescence, 2004-2005 (Collaboration research project UNICEF)

 

  1. Knowledge, Attitude, and Practice (KAP) Study of Tobacco Use by General Physicians, Iran Ministry of Health, Funded by World Health Organization (WHO), 2004-2005.

 

  1. Revising the counseling centers for university students, 2005-2006 (with IPPF).

 

  1. Capacity assessment of reproductive health organization, UNFPA, 2006-2007

 

  1. Exploring demand for health research by national policy makers: an empirical approach, WHO, 2006-2007

 

  1. A study on the trend of menopausal age trend in Tehran Lipid and Glucose Study  population, 2007

 

  1. The impact of menopause incidence of cardiovascular disorder and metabolic abnormalities (hypertension, diabetes ..), 2007

 

  1. Assessment of the prevalence of PCO based on NIH and Rotterdam criteria, 2007

  

  1. Assesment of the female reproductive morbidities , UNFPA and Ministry of Health and Medical Education, 2007-2008

 

  1. Prediction of menopause using Anti-Mullerian hormone, 2007-2008

 

  1. Survey on health Status of menopausal women , 2008

 

  1. Association of vitamin D receptor, PTH gene, Insulin and Adiponectin gene with PCOS, 2008-2010

 

  1. Motivators and barriers behaviors for prevention of non communicable disorders, 2008-2010

 

  1. The influence of serum lipoprotiens and body mass index on the age of menarche, 2009

 

  1. Age at menopause and its related factors (TLGS), 2009

 

  1. Discovery of novel loci for age at natural menopause in Iranian population, 2009-2011

 

  1. The comparison of Anti-Mullerian hormone serum concentration of women with poly cystic ovary syndrome and a eumenorrheaic women in Tehran Lipid and Glucose study, 2009-2011

 

  1. Genome-wide association of age at natural menopause (ANM) in Iranian community-based population: The Tehran Lipid and Glucose Study, 2009-2011

 

  1. Development and testing a module for assessing the female reproductive morbidities, 2009-2011Genome wide scans for menopausal age, 2009-2012

 

  1. Induction of polycystic ovary syndrome in the female rat, 2010

 

  1. The comparison of the effect prevalence of PCOS based on NIH and Rotterdam criteria, 2011

 

  1. A comparison study on the effect of natural versus surgical monopause on the metabolic parameters and cardiovascular complication, 2011

 

  1. The comparison of the effect of surgical & natural menopause on, metabolic parameters (2011-2012)

 

  1. Validation and replication of Genome-Wide Association Studies to identify putative novel loci associated with ANM in an Iranian population: The Tehran Lipid and Glucose Study, 2011-2012

 

  1. Effects of common variants in TCF7L2 and HHEX genes on polycystic ovary syndrome in Iranian patients, 2011 in progress

 

  1. Replication of loci from Genome-Wide Scan of European population influencing ANM in Iranian women: The Tehran Lipid and Glucose Study, 2012 in press

 

  1. Prediction of menopause using AMH serum concentration, 2012- in progress

 

  1. Evaluation of relation between history and duration of lactation with metabolic syndrom later in life in women above 15 years old participating: Tehran Lipid and Glucose study, 2012 in progress

 

  1. Assessment of hyperandrogenemia among women with anovulatory cycle in Tehran Lipid and Glucose study, 2008-2010

 

  1. Concept and quality of life assessment of the quality among women with polycystic ovarian syndrome: A qualitative study

 

  1. Molecular analysis of common tag polymorphisms in Insulin (INS), Follistatin (FTC) and Anti Mullerian Hormone (AMH) genes in patients affected with PCOS, 2011-2012

 

  1. Protective behaviors of women at risk for HIV/AIDS: Model development and testing

 

  1. The comparison of quality of life and sexual function in women with polycystic ovary syndrome: clinical and hormonal correlations, 2011-2012

 

  1. Study of Resistin, Chemerin, Insulin, and Fasting Blood Sugar in Obese PCOS Patients Comparing to Obese non-PCOS Controls, 2012

 

  1. Study of Adiponectin, Leptin, Viasfatin, and Omentin in Obese PCOS Patients Comparing to Obese non-PCOS Controls, 2012

 

  1. Assesment the consultation needs about reproductive health among women   at Alzahra educational hospital, 2012

 

  1. Development of Framework for decreasing C/S rate in Iran, 2012

 

  1. Comparison of the effect of different doses of fetal hyperandrogenemia on development of testis and sperm quality in male rat after puberty, 2012

 

  1. Designing a model to peredict menopausal age and its influencing factors using datamining models in Tehran Lipid and Glucose Study(TLGS), 2012

 

  1. Data bank of clinical, biochemical and sexual function of obese/overweight women with Polycystic Ovarian Syndrom, 2012
  2. Data bank of clinical, biochemical and sexual function of normal weight women with Polycystic Ovarian Syndrome, 2012
  3. The comparison between Yasmin & phlebotomy  on the insulin resistance and serum concentration of AMH and PSA among women with PCOS, 2012

 

  1. Investigation of pregnancy outcomes of pregnant women with subclinical hypothyroidism and negativeTPO antibody, 2013

 

  1. The examination of metabolic disorders in rats with polycystic ovary syndrome compared to control rats, 2013

 

  1. The association between serum concentration of anti mullerian hormon in men with cardiovascular disease, 2013

 

  1. Vitamin D Supplementation ( Single dose & multiple dose) in Pregnant Women:  Comparition the Effects on Neonatal Outcomes, 2013

 

  1. Vitamin D Supplementation ( Single dose & multiple dose) in Pregnant Women:  Comparition the Effects on Maternal Outcome, 2013

 

  1. Comparison of metabolic and cardiovascular complication of women with  polycystic ovary sysndrom (PCOS) with eumenorrhic non hirsute women in Tehran Lipid and Glucose Study, 2013

 

  1. Study on correlation between serum androgens and sexual function in menopausal women, 2013

 

  1. Study of Prevalence of thyroid dysfunction during pregnancy and its effect on the pregnancy outcome, 2013

 

  1. Assessment of the effect of Levothyroxine on pregnancy outcome of euthyroid pregnant women with positive TPO antibody: Randomized Clinical Trial, 2013

 

  1. Study and comparison of  CYP17A and FST genes expression in theca cells of normal and PCOS model rats, 2014

 

  1. Study and comparison of  GATA6 and StARD1 genes expression in theca cells of normal and PCOS model rats, 2014

 

  1. Comparison k-means cluster analysis, summed Likert scale  and  ROC curve to determine the normal range of androgen hormones in Iranian women, 2014

 

  1. The  effectiveness of interventions based on life style modification in women with polycystic ovarian syndrome, 2014

 

  1. To determine the degree of insulin resistance in obese women with polycystic ovary syndrome compared with non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis, 2014

 

  1. The comparison of the effect of ischemic postconditioning on myocardial ischemia-reperfusion injury in prenatally androgenized male and female rats compared to controls in adulthood, 2014

 

  1. Prediction of cardiovascular disease using serum concentration of Testosterone, LH, FSH, and PRL hormone: a population-based longitudinal study, 2014

 

  1. The study of cell proliferation, cytokine production and expression of CD8 marker in peripheral blood lymphocytes of women with polycystic ovary syndrome by co-culture with breast tumor cell lines, 2014

 

  1. The study of cell proliferation, cytokine production and expression of CD8 marker in peripheral blood lymphocytes of women with polycystic ovary syndrome by co-culture with ovarian tumor cell lines, 2014

 

  1. Investigation of diagnostic value of spectroscopy and chemometrics  methods on women with PCOs for determining of AMH and large mucin glycoprotein MUCB5 concentrations, 2014

 

  1. The study of Anti-tumor activity of peripheral blood lymphocyte in multiparous women compared with nulliparous women in Co-culture of  MDA-231 and MCF-7 tumor cell lines, 2014

 

  1. Comparison of effect of two interventional methods including of kegel excersice and sexual education on sexual function in postmenopausal women, 2014

 

  1. Comparison of universal and targeted screening for thyroid dysfunction in pregnant women, 2014

 

  1. Assessment of the association between circulating irisin and  glucose-dependent insulinotropic peptid with the development of polycystic ovary syndrome, 2014

 

  1. Strategic plan ro cesarean section rate reduction in I.R.IRAN, 2014

 

  1. Developing a valid and reliable instrument to assess Reproductive Health Status of men, 2015

 

  1. Assessment of the effect of Levothyroxine on pregnancy outcome in pregnant women with subclinical hypothyroidism and negative TPO antibody: Randomized Clinical Trial, 2015

 

  1. Investigation of pregnancy outcome in pregnant women with subclinical hypothyroidism and positive TPO antibody, 2015

 

  1. Investigation of the the Various Combined Oral Contraceptives effect on Clinical and Biochemical Parameters of Hyperandrogenism in patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis, 2015

 

  1. Hormone Therapy for Relieving Postmenopausal Vasomotor Symptoms : A systematic review, 2015

 

  1. A comparision of the effect of Low-dose oral contraceptives pills and Yasmin on the biochemical levels of hyperandrogenism, clinical - metabolic effects and quality of life of women with polycystic ovarian syndrome: A randomized clinical control trial, 2015

 

  1. Study of Kisspeptin antagonist effect on gonadotropin-releasing hormone (GnRH1) gene expression in hypothalamus of rats with polycystic ovary syndrome, 2015

 

  1. Evaluation of the prevalence of polycystic ovary morphology using ultasonography among reproductive age women participating in Tehran Lipid and Glucose Study, 2015

 

  1. Study on the Correlation between exercise and Sexual Function in Post-menopausal Women, 2015

 

  1. The prevalence of idiopathic hyrsutism in reproductive aged women: TLGS population based study, 2015

 

  1. The prevalence of subclinical hyperandrogenism among reproductive aged women in Tehran Lipid and Glucose Study (TLGS), 2015

 

  1. Nanostrutured transdermal phytoestrogen replacement therapy for relieving menopausal symptoms, 2015

 

 

  1. A comparision between Low-dose oral contraceptives pills and Marvelon effects on the biochemical levels of hyperandrogenism, clinical - metabolic effects and quality of life in women with polycystic ovarian syndrome: A randomized clinical control trial, 2016

 

  1. Effects of hormone replacement therapy on immunological factors in the postmenopausal period, a systematic review, 2016

 

  1. Nutrition, ovarian reserve, and age at menopause: a systematic review, 2016

 

  1. To determine the trend metabolic changes among women with polycystic ovary syndrome in Tehran Lipid and Glucose study, 2016

 

  1. Effects of Combined Oral Contraceptives with new progestin including cyproterone acetate, desogestrel and drospirenone on metabolic profile in women with polycystic ovary syndrome: A Systematic Review and Meta-analysis, 2016

 

  1. Effectiveness of ointment containing hops nanoparticles for relieving early menopausal symptoms, 2016

 

  1. o determine the insulin resistance and metabolic syndrome in women with polycystic ovary syndrome compared with women with polycystic ovary syndrome: a systematic review and meta-analysis, 2016

 

  1. Effect of Combined Oral Contraceptives on Hypothalamic–Pituitary–Gonadal axis in patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis, 2016

 

  1. Effectiveness of Family Physicians program on Maternal and Neonatal Indicators in Rural areas of Kurdistan and its promotion strategies, 2016

 

  1. prevalence of ovarian cyst in Tehran Lipid Glucose Study (TLGS), 2016

 

  1. determination of Scientific mapping of reproductive endocrinology research center, 2016
  2. Technical support to conduct a situation analysis on maternal health  (WHO), 2016
  3. Assessment of factors influencing physical activity in women with and without poly cystic ovary syndrome, 2016
  4. To comparison the maternal outcome in various screening strategies in gestational diabetes, 2016
  5. comparison the  neonatal outcome in various screening strategies in gestational diabetes, 2016
  6. Cost-Effectiveness of universal and risk-based screening for subclinical hypothyroidism in Iranian pregnant women, 2016
  7. Validation of billewicz scoring system for the detection of hypothyroidism in pregnant women, 2016
  8. The relationship between galactose diet in women with premature ovarian failure in TLGS, 2016
  9. Mimetical Signs and Symptoms of Thyroid Disorders in Healthy Pregnant Women, 2017
  10. Assessment of reproductive health indexes in TLGS, 2017
  11. Assessment of correlation between trend of changes in serum concentration of TSH and ovarian reserve identified according to AMH levels in reproductive aged women in Tehran Lipid and Glucose Study, 2017
  12. To determine the neonatal outcomes in pregnant women with first trimester fasting blood glucose of 92-100 mg / dL with fasting blood glucose less than 92 mg / dL, 2017
  13. Relationship between serum concentration  of  orexin A  after delivery with delivery mode(vaginal versus elective cesarean) and postpartum depressive symptoms and marriage satisfaction, 2017
  14. the effects of oral contraceptives on the serum concentration of adipokines including adiponectin, leptin,  and resistin in women with polycystic ovary syndrome, 2017
  15.  

 

 

 

book writing:

Reproductive morbidities among Iranian women, 2009

 

International patent:

Prediction of age of menopause using AMH serum concentration, 2010

 

Thesis:

  • Evaluation of efficiency of weighting methods in analysis of casecontrol studies with complex sampling for evaluating the factors related to pelvic organs prolapsed in Iranian women. MS Biochemistry.
  • The Study of AEC Coculture with Human Monocyte Macrophage Population in Induced Tollerogenic Monocyte, MS Immunology.
  • Evaluation on Chemerin levels in women with Polycystic ovary syndrome PCOS, MS Biochemistry.
  • Barriers to condom use among women at risk of HIV/AIDS: A qualitative study from Iran, PhD Reproductive Health.
  • Mental health status of menopausal women; a sequential mixed method study, PhD Reproductive Health.
  • Evaluation on Omentin levels in women with Polycystic ovary syndrome PCOS, MS biochemistry, MS Biochemistry.
  • Evaluation on Adipsin levels in women with Polycystic ovary syndrome PCOS, MS biochemistry, MS Biochemistry.
  • Evaluation on Liptin levels in women with Polycystic ovary syndrome PCOS, MS biochemistry, MS Biochemistry.
  • Designing a model to peredict menopausal age and its influencing factors using datamining models in Tehran Lipid and Glucose Study(TLGS), PhD Artificial Intelligence
  • Evaluation on TNFα and Adiponectin levels in women with Polycystic ovary syndrome PCOS, MS biochemistry, MS Biochemistry
  • Evaluation of efficiency of weighting methods in analysis of casecontrol studies with complex sampling for evaluating the factors related to pelvic organs prolapse in Iranian women. MS Biostatistics
  • Diagnostic investigation of polycystic ovarian disease by spectroscopy methods and chemometrics, MS chemistry
  • The Study of AEC Coculture with Human Monocyte Macrophage Population in Induced Tollerogenic Monocyte, MS Immunology
  • Relationship between serum concentration of orexin in pregnancy and postpartum and delivery mood (vaginal versus elective cesarean)and postpartum depressive symptoms and marriage satisfaction, MS Midwifery
  • Comparison of lifestyle between Polycystic Ovary syndrome women and controls and to design and evaluation of effectiveness of interventions based on lifestyle modification in patients with polycystic ovary syndrome, PhD Reproductive health
  • Production and assessment  of nanostructured transdermal phytoestrogen replacement therapy for relieving menopausal symptoms, PhD Reproductive health
  • Female gender scheme is disturbed by polycystic ovary syndrome: a qualitative study from Iran, PhD Reproductive health
  • Index lipid accumulation and insulin resistance in patients with polycystic ovary syndrome, Doctor of Medicine.
  • Comparison of metabolic and cardiovascular complication of women with  polycystic ovary sysndrom (PCOS) with eumenorrhic non hirsute women in Tehran Lipid and Glucose, PhD by Research
  • Effects of Vitamin D supplementation on cardiovascular disease`s  risk factors and quality of life in women with  polycystic ovary syndrome,  PhD Reproductive health
  • The effect of calligonum comosum on ovarian morphology, sex hormones anf fertility of Polycystic Ovary Syndrome, PhD Reproductive health
  • The Study of Prevalence of Vitamin D deficiency during Pregnancy and   Comparsion the  Effectiveness of  different Prescription Method of  Vitamin D3 on Obsteteic and Early Neonatal Outcomes in Pregnant Women with Vitamin D deficiency, PhD Reproductive health.
  • The examination of myometrium contraction in rats with polycystic ovary syndrome compared to control rats , MS Animal Biology
  • Relationship between serum Leptin levels  and weight gain & loss in pregnancy and postpartum, MS Midwifery
  • Instructional Design for Diagnosis and Treatment of Polycystic Ovary Syndrome for General Practitioners, MS Medical Education
  • Study and comparison of  CYP17A and FST genes expression in theca cells of normal and PCOS model rats, PhD Molecular Cell Biology
  • Comparisons the  efficacy of LD with other combine monophonic include antiandrogenic progesterone in women with hirsutism, PhD Reproductive health
  • The study of Antitumor activity of peripheral blood lymphocyte in multiparous women compared with nulliparous women in Co-culture of  MDA231 and MCF-7 tumor cell lines, MS Immunology
  • Assessment of sexual protective behavior of women at risk of HIV: Model developing and testing, PhD Reproductive health
  • the study of Relationship between maternal serum leptin level changes and vaginal delivery, elective C/S and duration of labor, MS Midwifery
  • Mental health status of menopausal women; a sequential mixed method study. PhD Reproductive health
  • Effectiveness of family physicians project on indicators of Maternal and neonatal Health program in Rural areas of Kurdistan and its promotion strategies: mixed method research explanatory followup. PhD Reproductive health

 

  • Study of Prevalence of subclinical hypothyroidsm during pregnancy and assessment of the effect of Levothyroxine on pregnancy outcome of euthyroid pregnant women with positive TPO antibody. PhD Reproductive health
  • A Study on sexual function of menopausal women to design of intervention and to evaluate its effect on sexual function. PhD Reproductive health
  • Relationship between the maternal serum ghrelin levels and weight gain in pregnancy, MS Midwifery
  • Determination of associated factors of natural menopause timing using weighted random forest, PhD Epidemiology.
  • The study of  Relationship between the level of maternal serum leptin and neonatal out come, MS midwifery
  • ……